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Abstract 
The mechanism of the regulation of cholesterol ester transfer protein by dietary 
fats and cholesterol was investigated using human cholesterol ester transfer protein 
transgenic mice fed monounsaturated fatty acid and saturated fatty acid enriched diets 
with or without cholesterol. Cholesterol inhibited protein activity and hepatic mRNA 
abundance in the monounsaturated fatty acid diet. However, cholesterol enhanced protein 
activity but had no effect on hepatic mRNA abundance in the saturated fatty acid diet. 
The molecular mechanisms of dietary lipid mediated regulation ofthe promoter activity 
of this gene were investigated using chimeric gene constructs harbouring sequential 
deletions of the gene promoter in SW 872 cell culture. Oleic acid and stearic acid had 
opposite effects indicating that the type of dietary fat alters gene regulation. There was 
interaction between cholesterol and fatty acids to regulate cholesterol ester transfer 
protein. 
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Chapter 1: Introduction 
1 
1.1 Atherosclerosis and Cholesterol Ester Transfer Protein 
Atherosclerosis is a leading cause of morbidity and mortality in the North 
American population, and plasma cholesterol levels are a major contributing factor. 
Death rates from coronary heart disease rise in a curvilinear fashion as a function of total 
plasma cholesterol (Dietschy, 1998). The increased levels of total plasma cholesterol, in 
particular an increase in plasma low density lipoprotein (LDL)- or very low density 
lipoprotein (VLDL)- cholesterol and a decrease in plasma high density lipoprotein 
(HDL) cholesterol, are related to an increased risk of atherosclerosis. The ratio of plasma 
HDL- to LDL-cholesterol is regulated by several factors, i.e. nutrients, hormones, and 
lipid transfer proteins such as cholesterol ester transfer protein (CETP). 
CETP is a 74 kDa hydrophobic glycoprotein and a member of the lipid transfer/ 
lipopolysaccharide binding protein gene family (Bruce et al., 1998a). It plays a major role 
in the reverse cholesterol transport pathway which removes cholesterol from the 
peripheral tissues and returns it to the liver. Cholesterol, taken up from the peripheral 
tissues by HDL, is esterified by lecithin: cholesterol acyl transferase (LCA T). CETP 
facilitates the transfer of esterified cholesterol in HDL in exchange for triglycerides in the 
apolipoprotein B containing lipoproteins, VLDL and LDL. The cholesterol ester in the 
lipoproteins is then removed from circulation by the liver via LDL-receptors. 
Cholesterol is also delivered to the liver from the diet in chylomicrons. The liver 
is the main site of cholesterol metabolism where the fate of cholesterol is further decided. 
In the liver, cholesterol may be catabolized to bile acids via the rate limiting enzyme 
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cholesterol ?a-hydroxylase (cyp7a) and secreted from the body as bile, or cholesterol is 
packaged into VLDL and secreted from the liver back into circulation. 
1.1.1 CETP as an atherogenic protein 
CETP is a puzzling protein as it may be considered atherogenic or anti-
atherogenic (Fielding et al., 1996). The decrease in HDL cholesterol caused by removing 
cholesterol ester from HDL in exchange for triglycerides by CETP leads this protein to be 
considered atherogenic. CETP expression in CETP transgenic mice reduces HDL-
cholesterol, an important component of the reverse cholesterol transport pathway 
(Agellon et al., 1991). The decrease in HDL-cholesterol is accompanied by a decrease in 
HDL particle size and apo A-I content (Dinchuk et al., 1995). CETP activity in the 
plasma of CETP transgenic mice increases the rate of plasma cholesterol esterification 
compared to control mice (Oliveira et al., 1997). Genetic CETP deficiency in humans is 
associated with decreased CETP activity and an increase in HDL-cholesterol that is 
linked to a decreased risk of coronary heart disease (Moriyama et al., 1998). The 
variation in the plasma CETP level is a major determining factor ofHDL levels in 
hyperlipidemic men, but less so in normolipidemic men (Bruce et al., 1998b ). On the 
other hand, other reports suggest that hyper-HDL cholesterolemic Japanese men with and 
without a CETP deficiency have no difference in the rate of coronary heart disease 
(Zhong et al., 1996). 
In animal studies, injection of antisense oligodeoxyribonucleotides against the 
CETP gene in rabbits showed decreased plasma total cholesterol concentrations and 
3 
increased plasma HDL cholesterol concentrations (Sugano and Makino, 1996). The aortic 
cholesterol content and aortic percent lesion to total surface area also showed a 
significant decrease. The plasma CETP and hepatic CETP mRNA levels decreased in 
these rabbits indicating that repression of CETP gene expression protects against 
development of atherosclerosis. The CETP vaccine developed to produce anti-CETP 
antibodies against residues 461 to 476 of human CETP, also caused an increase in HDL-
cholesterol, a decrease in LDL-cholesterol and a decrease in aortic atherosclerotic lesion 
area in cholesterol fed rabbits (Rittershaus et al., 2000). 
The CETP inhibitor JTT -705 acts to inhibit the transfer activity of CETP by 
forming a disulphide bond with the protein (Okamoto et al., 2000). In cholesterol fed 
rabbits, JTT -705 increased HDL-cholesterol, decreased LDL-cholesterol and decreased 
atherosclerotic lesions in the aortic arch by 70% compared to control rabbits. In a human 
randomized phase II dose-response study, JTT -705 was found to raise HDL-cholesterol 
levels with minor gastrointestinal side effects (de Grooth et al., 2002). The above reports 
direct our attention to consider that CETP is an atherogenic protein. 
1.1.2 CETP as an anti-atherogenic protein 
CETP is sometimes considered as an anti-atherogenic protein as it is involved in 
the removal of excess cholesterol from the peripheral tissues in the reverse cholesterol 
pathway (Fielding et al. , 1996). Smooth muscle cells in the intima and media of the 
human aorta produce CETP suggesting the arterial smooth muscle participates in removal 
of cholesterol esters from the arterial wall by CETP production (Ishikawa et al., 2001 ). 
4 
The expression of CETP in CETP transgenic mice inhibits the development of 
atherosclerosis but only in hypertriglyceridemic mice (Hayek et al., 1995). CETP 
expression in LCAT transgenic mice reduces atherosclerosis by restoring the functional 
properties ofLCAT-transgenic mouse HDL-cholesterol and promoting hepatic uptake of 
HDL-cholesterol ester (Foger et al., 1999). This supports the anti-atherogenic role of 
CETP in facilitating HDL-mediated reverse cholesterol transport and demonstrates the 
benefits of CETP expression in conditions of impaired reverse cholesterol transport. 
In contrast to the report ofMoriyana et al. (1998) in Hawaiian men of Japanese 
ancestry, CETP deficiency was found to be an independent risk factor for coronary heart 
disease despite hyper-HDL cholesterolemia (Zhong et al., 1996). CETP deficiency is 
thought to impair the reverse cholesterol transport pathway increasing the risk of 
atherosclerosis despite increased HDL cholesterol levels (Zhong et al. , 1996). CETP 
deficiency impairs cholesterol ester formation in plasma while LCAT concentration and 
activity is normal (Oliveira et al., 1997). CETP deficiency may impair the reverse 
cholesterol transfer pathway by secondary changes in the LCAT reaction explaining the 
high rates of atherosclerosis in genetic CETP deficiency. 
The conflicting data regarding the role of CETP in atherosclerosis that has 
emerged may reflect the intricate balance between the atherogenic and anti-atherogenic 
properties of CETP, which can be explained by two theories. One theory is that when 
plasma triglycerides are high, CETP transfers cholesterol esters to VLDL, but these 
particles are cleared too rapidly to tilt the net flux of cholesterol towards the arterial wall 
(Gianturco et al., 1982). Thus, under these conditions, CETP activity may inhibit 
5 
atherosclerosis by enhancing reverse cholesterol transport. On the other hand, when 
plasma triglycerides are normal, VLDL binds poorly to LDL receptors, hence would 
promote atherosclerosis (Fielding et al., 1989). These reports imply the importance of 
CETP in maintaining cholesterol homeostasis and suggest the need to understand the 
regulation of this protein. 
1.2 CETP gene expression 
The mRNA of CETP is 1.6 Kb and is expressed in the liver, spleen, adipose 
tissue, heart and skeletal muscle (Jiang et al., 1991). In humans, liver is the predominant 
source of plasma CETP but adipose tissue is also a predominant source of plasma CETP 
in obese subjects (Yamashita et al., 2000). The CETP mRNA is expressed in mature fat 
cells, stromal-vascular cells and preadipocytes in humans (Radeau et al., 1995). The 
CETP mRNA levels are higher in subcutaneous adipose tissue than visceral adipose 
tissue (Dusserre et al., 2000). CETP gene expression in human adipose tissue is a 
function of cell size and the membrane cholesterol content (Radeau et al., 1995). The 
CETP gene expression is regulated by nutrients and hormones (Bruce eta!. , 1998a). 
1.3 CETP gene structure 
The CETP gene contains 16 exons and 15 introns (Agellon eta!., 1990). The 
exons occupy only 8% of the CETP gene and range in size from 32 bp to 250 bp, while 
the introns range in size from 87 bp to - 6000 bp. The transcription initiation site is 
located at - 27 bp upstream of the translation initiation codon. The proximal promoter 
6 
region of the CETP gene contains a TAT A box and a SP 1 (pregnancy specific beta -1 
glycoprotein) binding site. 
The 5' regulatory region of the CETP gene is required for the regulation of CETP 
gene expression. The 5' regulatory region is required for the tissue-specific expression of 
CETP and also for the induction of CETP gene expression by saturated fat and 
cholesterol. This region contains binding sites for various transcription factors 
responsible for CETP regulation. The predominant expression of CETP in the liver and 
spleen ofCETP transgenic mice is controlled by 5' elements between -3400 and -570 bp 
in the CETP promoter (Oliveira et al., 1996). The -570 to- 370 bp region is also required 
for expression in the small intestine and other tissues, while elements in the -370 to 
-138 bp region contribute to adrenal expression. 
The CCAAT/ enhancer-binding protein alpha (C/EBPa.) has been found to trans-
activate the human CETP gene promoter (Agellon et al., 1992). The expression ofCETP 
was significantly enhanced by coexpressing C/EBP a. in HepG2 cells. The C/EBP q is 
expressed by mature adipocytes but is not expressed in stromal-vascular cells or 
preadipocytes, where only very low levels of C/EBP a. rnRNA are detectable (Radeau et 
al., 1998). C/EBPa. binds to the CETP gene promoter at~ -250 to -200 bp with sequence 
specific binding. 
A construct containing the - 138 bp region of the promoter shows a 70-fold 
increase in activity compared to a construct containing only the - 33 bp region (Gaudet et 
al., 1995). The -138 to - 33 bp region ofthe CETP gene promoter contains three tissue-
specific DNA-protein binding sites, A, B, and C, whose cognate proteins synergistically 
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activate transcription. Site A (-26 to -57 bp) contains overlapping DNA protein 
recognition regions for the zinc-finger proteins Sp-1 and Egr-1 (early growth response 
protein-1 ), and the consensus binding sequence for AP-2. Site B (-59 to -87 bp) contains 
2 PEA-3 (polyomavirus enhancer A binding protein) transcription factor binding motifs. 
Site C ( -93 to -118 bp) binds members of the nuclear hormone superfamily of 
transcription factors including Apolipoprotein A1 Regulatory Protein-1 (ARP-1) and its 
homologue Ear-3/ COUP-TF (chicken ovalbumin upstream transcription factor) (Gaudet 
et a/., 1995). ARP-1 and/or Ear-3/ COUP-TF overexpression increased the transcriptional 
activity by binding to the -300 to - 636 bp region of the CETP gene promoter but 
repressed the transcriptional activity when only the -300 region of the promoter was 
present. ARP-1 may be a transcriptional activator or repressor depending on promoter 
context. The -165 to -134 bp region of the CETP promoter is a retinoic acid receptor 
element (RARE) which binds the retinoic acid receptor (RAR) (Jeoung eta/., 1999). 
1.4 Dietary fats, cholesterol and CETP regulation 
Dietary saturated fats and cholesterol are known to alter CETP activity and gene 
expression in animal as well as human studies (Son eta/., 1986; Jiang eta/., 1992; 
Riemens eta/., 1999). The alterations in CETP are mainly due to an increase in the 
production and not due to a decrease in the catabolism of CETP (Bruce eta/., 1998a). 
The molecular mechanisms involved in cholesterol mediated regulation of CETP are 
beginning to be elucidated; however, the mechanism of regulation of CETP by dietary 
fats is unknown. 
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In human studies ofCETP regulation by dietary fats, Lichtenstein eta!. (2001) 
reported that the plasma CETP activity is highest in subjects consuming stick-margarine 
diet enriched in MUF A compared to margarines rich in PUF A, trans fatty acids or butter. 
In another study by van Tol eta!. (1995), a diet enriched with the trans fatty acid elaidate 
increased CETP activity in human subjects compared to diets enriched with linoleate or 
stearate. The substitution of trans elaidic acid for cis oleic acid increases CETP activity 
in men with a correlated decrease in HDL-cholesterol (Abbey et al., 1994). The National 
Cholesterol Education Program Step I diet (28% fat, 10% SF A) and a MUF A rich diet 
(38% fat, 22% MUFA) decrease plasma CETP concentrations compared to a SFA rich 
diet (38% fat, 20% SFA) in young, healthy, normolipidemic men (Jansen et al., 2000). 
Several reports are available on the regulation of CETP by dietary fats and 
cholesterol using animal models, however none of these reports clearly demonstrate the 
regulation of CETP by various types of dietary fats, and when fats are given along with 
cholesterol. St. Kitts vervet monkeys showed no difference in CETP activity among 
groups fed diets enriched in saturated (SF A), monounsaturated (MUF A), or n-6 
polyunsaturated (PUFA) fatty acids (Fusegawa et al., 2001). However, when the same 
diets were enriched with cholesterol the CETP activity increased. The positive 
correlations between CETP activity and VLDL- and LDL-cholesterol concentrations as 
well as the negative correlation between CETP activity and HDL-cholesterol 
concentrations were found in each diet group, with the highest strength of association in 
the saturated fat group. 
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In hamsters, feeding a 0.1% cholesterol-supplemented diet increased CETP 
activity (Kurushima et al., 1995a). However, the addition of 5% oleic acid to the 0.1% 
cholesterol-supplemented diet decreased CETP activity, while the addition of 5% linoleic 
acid did not affect CETP activity. The addition of 5% palmitic acid to the 0.1% 
cholesterol-supplemented diet increased CETP activity (Kurushima et al., 1995b ). 
Incidence of atherosclerosis increased significantly in transgenic mice expressing 
the simian CETP gene, when fed a diet high in saturated fat and cholesterol (Marotti et 
al., 1993). In transgenic mice expressing human CETP, the plasma CETP activity and 
hepatic CETP mRNA levels increased significantly when animals were fed diets rich in 
saturated fats and cholesterol (Jiang et al., 1992). The increase in hepatic CETP mRNA is 
caused by an increase in CETP transgene transcription due to the response of DNA 
sequences in the natural flanking region (NFR) of the CETP gene to the high cholesterol, 
high fat diet. Cholesterol synergistically increased the CETP activity and gene 
expression, when given along with saturated fats in transgenic mice. The CETP 
transgenic apolipoprotein E (apo E) and LDL receptor knockout mice show induction of 
hepatic CETP gene expression in response to a high cholesterol diet (Masucci-Magoulas 
et al., 1996). These reports indicate that hepatic CETP gene expression is regulated by a 
mechanism which senses plasma cholesterol levels independent of apo E and LDL 
receptors and does not require the classical receptor-mediated lipoprotein uptake. 
The CETP transgenic mice with the human CETP gene under the control of the 
apolipoprotein A-I promoter have a cholesterolemic response to dietary fats similar to 
that ofhumans (Chang et al., 2001). A high fat, PUFA enriched diet lowered plasma total 
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cholesterol in CETP transgenic mice compared to control mice and to CETP transgenic 
mice fed a high fat, SF A enriched diet. 
Many of these animal studies used chow based diets with the addition of 
cholesterol and dietary fat to examine the effect of cholesterol and dietary fat on CETP 
regulation. However, the composition of chow based diets is not consistent between 
suppliers or batches leading to variation in the nutrient content of the diet which 
introduces unknown factors affecting CETP regulation and cholesterol metabolism. 
Using a semipurified diet in feeding studies may be beneficial as it ensures the nutrient 
content is consistent between experiments with the only factor influencing CETP 
regulation and cholesterol metabolism being dietary lipids. 
1.5 Transcription factors involved in cholesterol-mediated CETP gene regulation 
The CETP 5' regulatory region contains binding sites for various transcription 
factors that regulate the CETP gene expression (Figure 1.1 ). Cholesterol increases CETP 
expression in transgenic mice expressing CETP gene under the control of its natural 
flanking region (Oliveira eta!., 1996). Cholesterol mediated stimulation of the CETP 
gene is suggested to be mediated via several transcription factors, i.e. sterol response 
element binding protein (SREBP), liver X receptor (LXR), and liver receptor 
homologue-I (LRH-1) (Oliveira et a!., 1996; Luo eta!., 2000; Luo et al., 2001). 
A high fat, high cholesterol diet increased the expression of CETP gene when a 
transgene composed of the - 138 to - 570 bp region of the CETP gene promoter linked to 
the human apo A-I reporter gene was expressed in the liver of transgenic mice (Oliveira 
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-----···> < ·----- - -----> - - -- --:> 
-580 ttctggggcacccagatgcagcgtcaaatgccatggaatacr.acagtgaggacatr..at:cctt.t.caagctttcaaatcaga -501 
Mf.C1F/MU;3F- DR 
------ -> <-------
-500 gcaagggaaaggtogatgctagagtttctctagcacccatgaagccctctccctttttctactgagttttactttacagg -421 
tNF-1 
> ----> ----> <---
- 420 caacagcaggctr.caagcttggggtcattgtcgggcaacagcatctggcaaQ!ck~ttcaatgtctttttctcatagtcatt -341 
-340 gtattttgccctctttctatttatggcaactgagagagaaagcttattcctagatatatgtatttaagtaaaaaa~t -261 
C/EBPa SBE 
------> ------> 
·-260 gaattcatggaaacatattaagcaattatccagataacataagggatggcaaaaatggtgcagatggtggaggggagaca -181 
RARE 
-----> -----> 
-180 agtagaagttggggtgc tcttgtt:gaatgtctggctctgaactctagaggaggccgcaggggctgggcaggaaggaggtg - 101 
LRH-1 
-----> -----> 
-100 aatctctggggccaggaagaccctgctgcccggaagagcctcatgttccgtgggggctgggoggacatacatatacgggc -21 
- 20 
+1 
I ... 
tccaggctgaacggctcgggccacttacacaccactgcctgataaccA~:h~~DQGC~~~D 
MetLeuAlaAla'IhrVal.LE.u'IbrLeuAlaLeu 
+60 
Figure 1.1: Complete nucleotide sequence between +60 and - 580 bp of the human 
CETP promoter region. Consensus elements for known transcription factors are shown: 
a tandem repeat of the sterol regulatory element (SRE) of the HMG-CoA reductase gene, 
retinoic acid receptor element (RARE), LXR, LRH-1, the ubiquitous nuclearfactor-1 
(NF-1), CIEBPa, hepatocyte nuclear factor- I (HNF-1), a nuclear hormone receptor 
(NHR), PEA-3, Spl, and the muscle-specific element MLCIF. Arrows indicate direct and 
inverted repeats (Modified from Oliveira et al. , 1996). 
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eta/., 1996). The -370 to -138 bp region contains the minimum CETP promoter element 
required for positive sterol response in CETP transgenic mice. This region contains a 
tandem repeat sterol response element (SRE) located at -211 to -187 bp identical to that 
which mediates sterol down regulation of the HMG-CoA (hydroxymethylglutaryl 
coenzyme A) reductase promoter (Chouinard eta/., 1998). The SRE binds SREBP-1 and 
Ying Yang 1 (YY1). The SREBP-1 transactivates the NFR-CETP transgene in CETP 
transgenic mice by binding to the SRE but this interaction is not required for positive 
sterol induction of CETP gene transcription by a high fat, high cholesterol diet. This 
suggests that the positive sterol response does not require binding of SREBP-1 and YY -1 
to the CETP proximal promoter, or the induction of CETP gene expression by cholesterol 
requires an independent positive sterol response factor. The -361 to - 138 bp region of the 
CETP gene promoter associated with a positive cholesterol response is designated the 
cholesterol response element (CRE) (Gauthier eta/., 1999). Deletion of the CRE results 
in the loss of25-hydroxy (25-0H) cholesterol mediated regulation ofCETP. SREBP-1a, 
-2 and YY1 trans activate the CRE element of the CETP promoter. 
The LXR is activated by hydroxylated cholesterol (Wolf, 1999). For full activity, 
the LXR must form a heterodimer with the retinoid X receptor (RXR) which is activated 
by 9-cis-retinoic acid. The LXRa is expressed mainly in the liver, and at lower 
concentrations in the kidney, intestine, spleen and adrenal glands, while LXR~ is 
expressed in most tissues. Derivatives of cholesterol i.e. 25-0H cholesterol and 22-0H 
cholesterol are potent inducers of the LXR. The sterol up regulatory response element 
(SURE) of the CETP gene promoter from -370 to -413 bp is required for the cholesterol 
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mediated induction of plasma CETP activity in CETP transgenic mice fed a high 
cholesterol diet (Luo et al., 2000). The SURE contains a direct repeat separated by 4 
nucleotides (DR4). The DR4 element 5'-GGGTCAttgtCGGGCA-3' is responsible for the 
sterol up regulation of the CETP promoter and is trans activated by LXRa/IUCRx and 
LXR13/IUCRx. The orphan nuclear receptor LRH-1 trans activates the CETP promoter in a 
sterol-dependent manner which potentiates the effect of LXRIRXR by binding to a 
proximal promoter element distinct from the DR4 site (Luo et al. , 2001). 
1.6 Fatty acids mediated gene regulation and peroxisome proliferator-activated 
receptors 
Fatty acids regulate the expression of several genes involved in lipid metabolism 
via the peroxisome proliferator-activated receptors (PP ARs) (Issemann et al. , 1990). 
PP ARa is expressed in hepatocytes, cardiomyocytes, and enterocytes, while the PP ARy is 
mainly expressed in adipocytes. Like LXR, the PP ARs also heterodimerize with RXR 
and bind to the peroxisome proliferator responsive element (PPRE) located in the 
promoter region of the responsive genes (Jump et al. , 1999). Unlike LXRIRXR that binds 
to a DR4 site, PPREs are DR1 (direct repeat sequence separated by one nucleotide) 
elements consisting of the consequence sequence 5 ' -AGGTCAxAGGT - CA-3' (Berger et 
al., 2002). 
The PP ARs are activated by peroxisome proliferators, clofibric acid, nafenopin, 
and WY 14643 (Jump et al. , 1999). Fatty acids such as caproic acid, stearic acid, oleic 
acid, elaidic acid, petroselinic acid, arachidonic acid and linoleic acid also activate PP AR 
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(Gottlicher et al., 1992). Short-chain saturated fatty acids (<C10) are poor activators of 
PP ARa., while longer chain fatty acids (C 1 0-C 16) have weak activity (Forman eta!., 
1997). Palmitic acid (C16:0), oleic acid (C18:1, n-9), petroselenic acid (C18:1, n-12), 
linolenic acid (C18:3, n-6 or n-3), linoleic acid (C18:2, n-6), and arachidonic (C20:4, n-6) 
acid all activate PP ARa. (Kliewer et al., 1997). The PP ARs also interact with the steroid 
receptor activator 1 (SRC-1) and PPAR-binding protein (PBP), which may act as 
coactivators ofthe PPARs (Jump et al., 1999). 
PP ARa. induces the expression of many genes involved in lipid metabolism 
including fatty acid transport protein, long chain fatty acyl-CoA synthase, enoyl-CoA 
hydratase /dehydrogenase multifunctional enzyme, keto-acyl-CoA thiolase, camitine 
palmitoyltransferase I, HMG CoA synthase, and various acyl-CoA dehydrogenases 
(Berger et al., 2002). PP AR activators such as fibrates are used in the treatment of 
hypertriglyceridemia. PP ARa. agonists also have anti-inflammatory and anti-
atherosclerosis effects via PP ARa. activation inhibiting cytokine-induced vascular cell 
adhesion and suppressing monocyte-macrophage migration (Berger eta!., 2002). PP ARa. 
activation in macrophages induces expression of the ATP-binding cassette transporter 
(ABC)-AI, a cholesterol efflux pump which is also a known target of the LXR. PP ARs 
are only one of several nuclear receptors which require the RXR as a heterodimer for 
DNA binding, raising the possibility that the activation ofPP AR may affect other 
signaling networks. 
The fatty acid- activated receptor (F AAR/PP A.Rs) mediates the transcriptional 
effects of fatty acids in preadipocytes (Amri et al., 1995). FAARIPPA.Rs is highly 
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expressed in mouse adipose tissue, small intestine, skeletal muscle, lung, heart, and brain, 
and is moderately expressed in the kidney, with low expression in the liver, spleen and 
testis. Palmitate and 2-bromopalmitate induce the expression ofFAARIPPAR,s mRNA in 
Ob 1771 preadipocytes. The exposure ofF AARIPP ARs expressing cells to fatty acids 
induces the expression of mRNA for several genes. The F AARIPP ARs and~ or 
RXRp bind cooperatively to the PPRE. 
1. 7 SW 872 cells and CETP regulation 
SW 872 is a human liposarcoma cell line that was first shown to synthesize and 
secrete CETP by Richardson et al. (1996). The SW 872 cell line has significant and 
reproducible levels of CETP activity. CETP secretion from SW 872 cells is 50 times 
greater than from HepG2 cells with the secretion of CETP into the medium increasing 
with time. The addition ofLDL cholesterol and 25-0H cholesterol increased the secreted 
CETP activity and mRNA abundance in the SW 872 cells (Richardson et al., 1996; 
Gauthier et al., 1999). The addition of oleate to the growth medium in the absence of 
agents required for cellular differentiation caused a rapid accumulation of triglyceride-
containing droplets and increased CETP activity and mRNA levels (Izem et al., 2001). 
Transfection of SW 872 cells with the antisense oligonucleotide targeting human CETP 
mRNA decreases CETP secretion and cholesterol biosynthesis. SW 872 cells also express 
PP ARa and PP ARy which are important transcription factors involved in the regulation of 
genes oflipid metabolism (Jiang et al., 2001). These findings suggest that SW 872 cells 
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might be an appropriate cell line to study the regulation of CETP by various fatty acids 
and cholesterol. 
1.8 Goals 
Dietary lipids are an important constituent ofWestem diets, and the quality of 
dietary fats alters the LDL-/HDL-cholesterol ratio. The CETP plays an important role in 
maintaining LDL-/HDL-cholesterol ratio. Saturated fats increase CETP gene expression, 
and the addition of cholesterol synergistically enhances the increase in CETP gene 
expression. Cholesterol mediated regulation of the CETP gene is via LXRaiRXRa, SRE 
and LRH-1 (Luo eta/., 2000; Oliveira et al., 1996; Luo et al., 2001). However, the 
mechanism for the regulation of CETP by various dietary fats is not known. It is also not 
known whether cholesterol, given along with various dietary fats synergistically regulates 
CETP. 
To investigate the regulation of CETP by various dietary fats, and to understand 
whether cholesterol given along with various dietary fats has different effect on CETP 
regulation, we used transgenic mice expressing human CETP gene under the control of 
its natural flanking region and designated these as CETP-TG mice and age matched litter 
mates not expressing CETP designated as non-TG mice. Plasma CETP activity and 
hepatic CETP mRNA levels were used to examine the effect of dietary fats and 
cholesterol on CETP regulation. Cell culture studies were performed using SW 872 cells 
as a model to further understand the molecular mechanisms involved in dietary fat and 
cholesterol mediated regulation of the CETP gene. Chimeric gene constructs harbouring 
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serial deletions of the CETP gene promoter linked to chloramphenicol acetyl transferase 
as a reporter were used in transfection experiments to investigate the effects of dietary 
fats and cholesterol. These studies will help in understanding the regulation of CETP by 
dietary lipids and may prove to be beneficial in designing therapeutic strategies using diet 
as a therapy. 
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Chapter 2: Methods 
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2.1 Reagents 
Pure fatty acids (stearic acid, 18:0; oleic acid 18:1), acetyl CoA, o-nitrophenyl-~­
D-galactopyranoside (ONPG), and fatty acid free-bovine serum albumin (BSA) were 
purchased from Sigma-Aldrich (Oakville, ON). Fetal bovine serum (FBS), Dulbecco's 
modified Eagle's media (DMEM), F12 nutrient mix, human insulin, and human 
transferrin were purchased from Gibco-BRL Life technologies (Burlington, ON). D-
threo-[ dichloroacetyl-14C] - chloramphenicol and [ 4-14C]-cholesterol were purchased 
from Amersham Pharmacia Biotech (Baie d'Urfe, Quebec). Tristearin was purchased 
from ICN Biomedicals (Montreal, Quebec). Bertelli Lucca Extra Virgin Olive Oil was 
purchased from a local supermarket. 
2.2 Animals and diets 
Heterozygous transgenic mice expressing human CETP (C57BL/6J background) 
under the control of its native flanking region (3.4 kb NFR) were a gift from Dr. Alan 
Tall, Columbia University, NY (Jiang et al., 1992). These mice were crossed with 
C57BL/6J mice obtained from Charles River Laboratories (Wilmington, MA). Mice were 
housed under a 12-hour light/dark cycle and fed a standard chow diet prior to the 
initiation of the experimental diet study. At eight weeks of age, mice were tail bled and 
plasma was assayed for CETP activity using the CETP Activity Assay Kit (Roar 
Biomedical, Inc., Columbia University, NY). Based on the presence or absence of CETP 
activity the mice were labeled as non-transgenic (non-TG) or transgenic (CETP-TG) 
m1ce. 
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Eight week old CETP-TG and non-TG mice were fed a semi-purified diet (custom 
made basal mix without 20% fat from ICN Biomedicals, Inc. Montreal, Quebec) 
containing 20% (w/w) fat from either olive oil (enriched in 18:1, a monounsaturated 
fatty acid; MUFA diet), or tristearin (18 :0, a saturated fatty acid enriched diet; SFA diet) 
in the presence or absence of 1% cholesterol, for 2 weeks. Flax seed oil (1% w/w) was 
added to all semipurified diets to ensure an adequate supply of essential fatty acids. The 
fatty acid composition of the diets was determined by gas-liquid chromatography (Table 
2.1 ). The mice were given free access to food and water. Body weight was determined at 
the beginning and end of the diet study. Food was replenished every other day and food 
consumption was recorded. At the end of the diet study mice were sacrificed and blood 
was collected by cardiac puncture in tubes containing EDTA. Livers were removed, 
weighed and quick frozen in liquid nitrogen. Liver samples were stored at -70°C until 
further use. 
2.3 Plasma and liver lipid analysis 
Lipids were extracted from liver samples by homogenizing 50 mg of liver in 2 ml 
chloroform/methanol (2:1) (Folch et al., 1957). The lower organic phase was dried under 
nitrogen, and resuspended in 1 00 1-11 of isopropanol. The plasma and liver lipids were 
assayed for total cholesterol and triacylglycerol concentrations using enzymatic methods 
(kit# 402 for total cholesterol and kit# 344 for triacylglycerol, Sigma-Aldrich 
Diagnostics, St. Louis, MO). 
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Table 2.1: Fatty acid composition of the dietary fat. 1 
Fatty acid MUFA SFA 
Diet Diet 
%w/w 
14:0 0.31 0.25 
16:0 0.28 0.72 
16:1 10.15 15.56 
18:0 2.68 51.69 
18:1 63.28 13.83 
18:2 (n-6) 8.67 4.87 
18:3 (n-3) 4.33 12.65 
~SFA 3.27 52.66 
~MUFA 73.43 29.39 
~PUPA 13.00 17.52 
1 The fatty acid composition ofthe MUFA and SFA diets were determined by gas 
chromatography as outlined in Methods. Fatty acid composition is represented as % w/w. 
Abbreviations used: ~SF A, sum of saturated fatty acids, ~MUF A, sum of 
monounsaturated fatty acids, ~PUF A, sum of polyunsaturated fatty acids. 
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LDL and VLDL were selectively precipitated from plasma samples by MgCh/ 
phosphotungstic acid precipitating reagent (kit# 352-7, Sigma-Aldrich Diagnostics, St. 
Louis, MO). The supernatant containing the HDL-cholesterol was assayed for cholesterol 
concentration using enzymatic methods (kit# 402, Sigma-Aldrich Diagnostics, St. Louis, 
MO). The concentration ofLDL-cholesterol was calculated from the total cholesterol, 
HDL-cholesterol, and triacylglycerol concentrations by using the conversion formula: 
LDL =total cholesterol - HDL- (triacylglycerols/2.2) (Friedewald eta/., 1972). All 
assays were performed in duplicate. 
2.4 CETP activity assay 
The CETP activity in the plasma samples was assayed using the CETP Activity 
Assay kit (Roar Biomedical, Inc., Columbia University, NY) or by a previously published 
radioactive method with modifications (Tall eta/., 1987). To measure the CETP activity 
using the fluorometric activity kit method, 2 )..ll of plasma was diluted to 20 )..ll with sterile 
deionized water. Ten microlitres of the diluted plasma was combined with 3 )..ll of donor 
particle (synthetic phospholipid and cholesterol esters linked to a fluorescent label 
nitrobenzooxadiazol-flourophor (NBD-CE) and 3 )..ll of acceptor particle (VLDL) in 150 
)..ll total volume ofbuffer (10 rnM Tris, 150 mM NaCl, 2 mM EDTA, pH 7.4). The 
reaction was carried out at 37°C for 3 hours. The reaction mix was transferred to a 96-
well microplate and read in the Spectra Max Gemini fluorescence spectrophotometer at 
excitation wavelength of 465 nm and emission wavelength of 535 nm. The fluorescent 
cholesterol ester is present in a self-quenched state when it is contained within the core of 
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the donor. The CETP-mediated transfer is determined by the increase in fluorescence 
intensity (emission wavelength, 535 nm) as the fluorescent cholesterol ester is removed 
from the self-quenched donor to the acceptor. The fluorescence readings were 
standardized to pmole NBD-CE transferred I 3 hour by plotting a standard curve to derive 
the relation between fluorescence intensity and mass transfer generated by dispersing the 
donor in isopropanol. The unquenched fluorescence intensity of the fluorescent 
cholesterol ester contained within the donor particle core was determined by dispersing 5 
~-tl of donor in 2 ml of 100% isopropanol. Serial dilutions of the dispersion were made to 
generate a standard curve of fluorescence intensity (excitation 465 nm/emission 535 nm) 
versus mass of fluorescent cholesterol ester. 
For the radioisotope CETP activity assay, lipoproteins (LDL; density 1.024-1.063, 
and HDL; density> 1.125) were isolated from human plasma (Murdoch eta/., 1994). The 
HDL fraction was radiolabelled using [4-14C]-cholesterol (Tall et al., 1987). Plasma 
samples were incubated with LDL and radiolabelled HDL for 6 hours in incubation 
buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 2 mM diethyl-p-
nitrophenylphosphate). The LDL fraction was then precipitated using heparin and MnC}z 
on ice, and the radioactivity in the supernatant and the precipitate was counted. The 
results are expressed as percent cholesterol ester transferred over 6h (% CE transfer). 
2.5 CETP mRNA abundance 
To detect changes in CETP mRNA abundance, total RNA from mouse livers was 
isolated according to standard procedures (Chomczynski eta/., 1987) and stored at -20°C. 
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The RNA concentration was determined and the integrity of the RNA was checked by 
running a 1% agarose gel in borate buffer. Hepatic CETP mRNA concentrations were 
determined by reverse transcription and in vitro DNA amplification. Complementary 
DNA was synthesized from total liver RNA (1 f..!g) using Superscript reverse transcriptase 
(Gibco BRL Life Technologies, Inc., Burlington, ON) and then used as templates for in 
vitro DNA amplification. CETP and GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) mRNA sequences were amplified using specific primers (human CETP 
sense 5 '-CGTCATCTCTAACATCATGGCCGA-3 ', antisense 5 ' -ATCTTGGGCATCTTGAG-
GCAGTGGA-3'; mouse GAPDH sense 5'-GAGCCAAACGGGTCATCATC-3', antisense 
5'-CATCACGCCACAGCTTTCCA-3'). No amplification products were detectable in the 
absence of reverse transcriptase. In preliminary experiments, the PCR (polymerase chain 
reaction) amplifications were carried out using different numbers of cycles, the 
expression levels were in the linear range using 30 cycles for both CETP and GAPDH. 
Thus, for all subsequent experiments 30 cycles were used to amplify CETP and GAPDH. 
The PCR reactions were performed in duplicate, and the products were resolved on a 
1.2 % agarose gel. The representative bands were quantitated using gel documentation 
system. The amount of CETP mRNA was normalized to GAPDH mRNA content. 
2.6 Microsome preparation 
Microsomes were prepared from liver homogenates as previously described 
(Cheema eta!., 1997). In brief, 300 mg liver samples were homogenized in 3 ml of 
buffer I (50 mM KCl, 1 mM EDTA, 100 mM K2P04 pH 7.4, 50 mM KF, 5 mM DTT, 
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300 mM sucrose). The homogenate was centrifuged at 9000 rpm, 4°C, for 20 minutes. 
The supernatant was transferred to Beckman ultracentrifuge tubes and centrifuged at 
35000 rpm, 4°C, for 70 minutes in the Beckman SW 55 rotor. The microsome pellet was 
resuspended in 500 ~1 ofbuffer II (50 mM KCl, 1 mM EDTA, 100 mM K2P04 pH 7.4, 
50 mM KF, 5 mM DTT) and stored at -70°C. The total protein content ofmicrosomes 
was determined using the Lowry Protein Assay (Lowry et al., 1951 ). The free cholesterol 
content of the microsomes was determined using the Free Cholesterol enzymatic 
colorimetric method (kit# 274-47109 E, Wako Chemicals Inc., Richmond, VA). 
2.7 Cholesterol 7a-bydroxylase (cyp7a) assay 
Microsomal cyp7a activity was measured following the conversion of[4-14C]-
cholesterol to ?a-hydroxy-[ 4-14C]-cholesterol as described previously (Agellon, 1997). 
Microsomes containing 100 j.lg of protein were incubated in the presence of 125 j..tl of2x 
cyp7a assay buffer (200 mM K2P04, pH 7.4, 2 mM EDTA, 100 mM KF), 4.5 ~1 ofthe P-
cyclodextrin/ [ 4-14C]-cholesterol cocktail ( 45% 2-hydroxypropyl-P-cyclodextrin, 0.9% 
NaCl, 0.18 mg/mL cholesterol, 34 j..tCi [ 4-14C]-cholesterol) and 20 j..tl of 10 mg/ml 
NADPH solution in a total volume of250 j..tl at 37°C for 15 minutes. The reaction was 
stopped by adding 20 j..tl of 5 M NaOH and the reaction products were extracted using 
ethyl acetate. The products were separated on TLC plates using an ethyl acetate: toluene 
(3 :2) solvent system. The plates were exposed to a phosphorimager screen, and bands 
corresponding to ?a-hydroxy-[ 4-14C]-cholesterol were quantitated. The cyp7a activity 
was expressed as pmol/min/mg protein. 
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2.8 Cloning of the human CETP gene promoter and chimeric gene construction 
Chimeric gene constructs harbouring sequential deletions of the human CETP 
gene promoter linked to chloramphenicol acetyl transferase (CAT) as a reporter (Figure 
2.1) were previously designed by Dr. S. Kaur. A 1520 bp PCR fragment containing 
360 bp of the 5' regulatory region, part of exon 1, intron 1 and exon 2 were generated 
using the published sequence of the human CETP gene (GenBank Accession numbers 
U71187 & M32992). The PCR product was digested with Hind III and the resulting 
fragment containing 300 bp of the CETP gene 5' regulatory region was linked to CAT in 
pCAT.Basic vector (Promega) and designated 300CETP.CAT. The 150CETP.CAT was 
constructed by digesting the 300CETP.CAT with Xba I. For the longer CETP gene 
promoter region, the 1520 bp PCR fragment was used to screen a human chromosome 16 
genomic library. An Xba I-Xba I fragment containing sequences from -3420 to -138 was 
obtained and cloned into 150CETP.CAT to generate 3200CETP.CAT. The 
3200CETP.CAT was digested with Kpn I to generate 650CETP.CAT. The sequences of 
all cloned CETP fragments were confirmed. 
Restriction mapping of3200CETP.CAT, 650CETP.CAT, and 150CETP.CAT 
chimeric gene constructs was used to confirm the identity of the plasmids. The published 
sequences of the human CETP gene and the pCAT .Basic plasmid were used to choose 
the restriction enzymes. Restriction digests were performed using standard techniques. 
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Figure 2.1: Structure of the human CETP.CAT gene chimeras. Open boxes depict the 
human CETP promoter; hatched boxes represent the CAT structural gene sequence; solid 
boxes represent the SV 40 region. X represents the digestion site for Xba I, K represents 
the digestion site for Kpn I, and H represents the digestion site for Hind III. 
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2.9 Preparation of competent E. coli DHSa cells 
An overnight culture (1 ml) ofDH5a cells was used to inoculate 50 ml of 2xYT 
medium which was incubated at 37°C to an optical density of0.3 to 0.5 (approximately 
2 hours). The culture was transferred to chilled tubes and centrifuged at 2000 rpm for 
10 minutes at 4°C. The cell pellet was resuspended in 25 ml ofRF1 (30 mM KOAc, 
100 mM RbCl, 10 mM CaCh, 50 mM MnCh, 15% glycerol) and incubated on ice for 
30 minutes. The cells were centrifuged at 2000 rpm for 10 minutes at 4°C, resuspended in 
2 ml of ice cold RF2 (10 mM MOPS, 75 mM CaClz, 10 mM RbCl, 15% glycerol) and 
incubated on ice for 15 minutes. The cell suspension was distributed in 100 J.d portions to 
1.5 ml tubes, flash frozen on dry ice, and stored at -70°C. 
2.10 Introduction of DNA into E. coli and large scale preparation of plasmid DNA 
DNA (1 ~g) was added to competent DH5a cells, mixed gently and placed on ice 
for 30 minutes. The cells were heat shocked for 90 seconds at 42°C, returned to ice for 
30 seconds and 1 ml of2xYT media was added to the cells. The cells were incubated at 
37°C for 30 minutes and selected for ampicillin resistance by plating on 2xYT media 
containing ampicillin. A single colony was picked to inoculate 5 ml of 2x YT media 
containing ampicillin, and fresh overnight culture was used to inoculate I litre of2xYT 
media containing ampicillin. This procedure was performed for 150CETP.CAT, 
650CETP.CAT, 3200CETP.CAT, C/EBPu, PPARu, RXR, LXRa, pCAT.Basic, and 
p-galactosidase. 
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The standard alkaline lysis procedure was used for large scale plasmid DNA 
purification (Sambrook et al., 1989). The DNA pellet was dissolved in 8 ml ofTE buffer 
(5 mM Tris, pH 8.0, 1 mM EDTA) and used for CsCl density gradient centrifugation. 
The plasmid DNA band was collected, and ethidium bromide was removed using water-
saturated n-butanol. DNA was precipitated and dissolved in low TE buffer (5 mM Tris, 
pH 8.0, 0.1 mM EDTA). The purity of the purified DNA plasmids was confirmed using 
agarose gel electrophoresis and the plasmid identity was confirmed by restriction digest 
as explained above in section 2.8. All DNA samples were filter sterilized and stored at 
-20°C. 
2.11 Cell culture 
SW 872 cells (human liposarcoma cells) were purchased from the American Type 
Culture Collection (ATCC, Manassas, VA). The cells were grown in a humidified 
atmosphere of5% C02/95% air in Dulbecco's modified Eagle's media (DMEM)/ F12 
(3: 1 ), 5% FBS, 10 mM HEPES (N-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid) 
and 50 f.lg/ml gentamycin at 37°C according to previously published methods 
(Richardson et al., 1996). This media was designated as regular growth medium. The 
cells were trypsinized using 0.25% trypsin and subcultured 1:5 at 37°C, 5% C02. 
When cells reached 70% confluence, media was removed and replaced by 
differentiation growth media containing DMEM/ F 12 (3: 1 ), 10 mM HEPES, 50 J..tg/ml 
gentamycin, 100 f.lg/ml fatty acid free BSN oleic acid, 1 J..tg/ml insulin, and 1 f.lg/ml 
transferrin for 24 h. After 24 hours, the differentiated cells were washed with phosphate 
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buffered saline (PBS- 0.14 M NaCl, 2.7 mM KCI, 4.3 mM Na2HP04.1H20 1.5 mM 
KH2P04, pH 7.4) and fresh regular growth medium (without serum) containing DMEM/ 
F12 (3:1), 10 mM HEPES and 50 !J.g/ml gentamycin was added. Cells were grown under 
these conditions for 24 h prior to transfection. 
2.12 Oil Red 0 staining and lipid analysis of SW 872 cells 
To investigate whether SW872 cells accumulate lipids when grown in the 
presence of insulin and oleic acid, the cells were grown to 70% confluency in regular 
growth medium. Growth media was then replaced by differentiation media or regular 
growth medium without FBS for 48 h. At 48 h, the cells were stained with Oil Red 0 
(Boone et al., 1986). Stained cells were viewed under a microscope for detection oflipid 
accumulation and photographed using a Nikon Eclipse 600 microscope with a Nikon VIII 
camera. For lipid extraction, the cells were grown to 70% confluency, media was 
aspirated and fresh medium, either regular growth medium without FBS or differentiation 
medium was added to the cells. The cells were harvested at various time points and 
lipids were extracted using chloroform/methanol (2: 1) (Folch et a!. , 1957). The lower 
organic phase was dried under nitrogen, and resuspended in 100 !J.l isopropanol. The 
lipids were assayed for total cholesterol and triacylglycerol concentrations using 
enzymatic methods (kit # 402 for total cholesterol and kit # 344 for triacylglycerol, 
Sigma-Aldrich Diagnostics, St. Louis, MO). 
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2.13 CaP04 transfection of eukaryotic cells 
To investigate the effect of various fatty acids on CETP gene regulation, the 
CETP chimeric gene constructs (150CETP.CAT, 650CETP.CAT, and 3200CETP.CAT) 
were transfected into differentiated SW 872 cells. DNA-CaP04 complex was made using 
0.5 ml ofHBS (0.14 M NaCl, 5 mM KCl, 0.7 mM NazHP04.1HzO, 5.6 mM dextrose, 
21 mM HEPES, pH 7.4), a total of30 ).lg ofDNA, and 32 J.!l of2 M CaCh (Grahem et 
al., 1973). The total amount of DNA was kept constant by adding sonicated salmon 
sperm DNA. The cells were cotransfected with p-galactosidase and C/EBP a· The 
p-galactosidase is used as a control for transfection efficiency and C/EBP a is used since 
the coexpression ofC/EBPa is required for CETP.CAT expression in SW 872 cells 
(Chapter 3). The growth medium was aspirated from the cells and DNA-CaP04 complex 
was added to the cells and incubated for 20 minutes at room temperature. Regular growth 
medium containing delipidated serum (2.5% FBS) was added to the transfected cells. 
Fatty acids complexed to fatty acid free-BSA and 25-0H cholesterol dissolved in DMSO 
(dimethyl sulfoxide) were added to the transfected cells at indicated concentrations 
(50 J.!M for fatty acids and 4 J.lg/ml for 25-0H cholesterol). Control cells received the 
vehicle alone. The transfected cells were kept for 24 hours in a 5% C02 environment at 
37 °C. Cells were washed twice with PBS, replenished with regular growth medium 
containing delipidated serum (5% FBS) and kept in 5% C02 environment at 37°C for an 
additional 24 hours. Cells were harvested; the cell pellet was resuspended in 175 J.ll of 
250 mM Tris HCI, pH 8.0 and freeze/thawed six times. After centrifugation, the 
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supernatant was used to assay for chloramphenicol acetyl transferase activity and P-
galactosidase activity. 
2.14 Measurement of p-galactosidase activity 
Transfected cell extract and 2x P-galactosidase assay buffer (200 mM sodium 
phosphate, pH 7.3, 2 mM MgClz, 100 mM P-mercaptoethanol, 1.33 g/ml ONPG) were 
mixed in equal ratio and incubated at 37°C for 1 h. The reaction was stopped with 1 M 
sodium carbonate and the absorbance was read at 420 nm using the Spectra Max 190 
plate reader. 
2.15 Measurement of chloramphenicol acetyl transferase (CAT) activity 
The cell extract from transfected cells was heated to 65°C for 10 minutes to 
inactivate endogenous deacetylase activity, cooled on ice, and mixed with a cocktail 
containing 2 J.!l ofD-threo-[ dichloroacetyl-14C]- chloramphenicol and 113 J.!l of 250 mM 
Tris HCl (pH 8.0). The final volume was adjusted to 160 J.!l with 250 mM Tris HCl, 
pH 8.0. The reaction was initiated by adding 20 J.!l of freshly prepared acetyl CoA 
(3 .5 mg/ml) and incubated at 37°C for 1 hour. The reaction products were extracted using 
ethyl acetate and separated on TLC plates using chloroform: methanol (95:5) solvent 
system. The TLC plates were exposed to a phosphorimager screen and bands of mono-
and di-acetylated 14C-chloramphenicol were quantitated. The CAT activity was 
normalized to f3-galactosidase activity and the control samples in each experiment were 
assigned a value of one. 
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2.16 Statistical analysis 
All assays were performed in duplicate. The CAT and p-galactosidase activity 
data from the cell transfection experiments were analyzed using Student's t test. The data 
from the mice experiments were analyzed using ANOV A. The differences between 
groups were considered significant ifp<0.05 (Steele and Torie, 1980). Values without a 
common superscript are significantly different. 
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Chapter 3: Results 
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3.1 Effect of a high fat diet enriched in monounsaturated fatty acids (MUFA) on 
cholesterol metabolism 
3.1.1 Body weight and liver weight of mice fed MUFA diet 
Body weights were recorded to ensure that mice were eating the experimental 
diets. The CETP-TG and non-TG mice fed MUF A, with or without dietary cholesterol 
showed no significant differences in body weight over a two week feeding period (Table 
3.1). There were no significant differences in liver weights in CETP-TG and non-TG 
mice fed MUF A diet with or without dietary cholesterol. 
3.1.2 Plasma lipid levels 
Changes in plasma lipid levels of CETP-TG and non-TG mice fed a diet enriched 
in MUFA with or without cholesterol are shown in Table 3.2. Total plasma cholesterol 
concentrations of CETP-TG mice fed MUF A diet were significantly lower compared to 
non-TG mice fed the MUF A diet (21% decrease, p=0.036). However, when cholesterol 
was added to the MUF A diet, there was no significant difference in the total plasma 
cholesterol concentrations of CETP-TG or non-TG mice. The LDL-cholesterol 
concentrations were not different between CETP-TG and non-TG mice fed a diet 
enriched in MUF A. The addition of cholesterol to the MUF A diet caused 1.30 fold 
(p=0.02) and 1.28 fold increase (p=0.009) in LDL-cholesterol concentrations in CETP-
TG and non-TG mice respectively. The CETP-TG mice showed a significant decrease in 
HDL-cholesterol concentrations compared to the non-TG mice (p=0.019). Addition of 
cholesterol to the MUF A diet had no significant effect on HDL-cholesterol 
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Table 3.1: Body weight and liver weight of CETP transgenic (CETP-TG) and non 
transgenic (NON-TG) mice fed MUFA diet in the presence or absence of 1% 
cholesterol.1 
Group Diet n Original body Final body Liver 
weight (g) weight (g) weight (g) 
CETP-TG MUFA 4 21.30± 1.59 23.10± 1.49 1.16±0.14 
MUFA+ 8 21.84±2.71 23.81±2.85 1.18±0.21 
cholesterol 
NON-TG MUFA 8 23.30± 1.96 25.70±2.72 1.25±0.23 
MUFA + 5 24.30±2.16 27.72±3.69 1.52±0.36 
cholesterol 
1 Mice were weighed at the beginning and conclusion of the experiment. The livers were 
collected and weighed at the conclusion of the experiment. Values shown are mean ± 
standard deviation. 
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Table 3.2: Plasma lipid concentrations of CETP transgenic (CETP-TG) and non 
transgenic (NON-TG) mice fed a diet enriched in MUFA. 1 
Group Diet n Total LDL- HDL- Total 
Cholesterol Cholesterol Cholesterol Triacylglycerol 
(mmol/L) (mmol/L) (mmol/L) (mmol/L) 
CETP-TG MUFA 4 1.75±0.25b 0.79±0.09bc 0.79±0.13b 0.20±0.04b 
MUFA+ 8 1.91 ±0.33ab 1.03±0.12a 0.74±0.15b 0.24±0.06ab 
cholesterol 
NON-TG MUFA 8 2.21 ±0.273 0.71 ±0.08c 1.34±0.37a 0.29±0.07ab 
MUFA+ 5 2.35 ±0.64ab 0.91 ±0.08ab 1.85±0.81 a 0.30±0.03a 
cholesterol 
1 Values shown are mean ± standard deviation. Values without a common superscript are 
significantly different. (p < 0.05). 
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concentrations in CETP-TG or non-TG mice. Total plasma triacylglycerol 
concentrations were not significantly different between the CETP-TG and non-TG mice 
fed a diet enriched in MUF A. Addition of cholesterol to the MUF A diet had no 
significant effect on total plasma triacylglycerol concentrations in both CETP-TG and 
non-TG mice. 
3.1.3 Hepatic lipid levels 
Changes in hepatic lipid levels ofCETP-TG and non-TG mice fed a high fat diet 
enriched in MUFA with or without cholesterol are shown in Table 3.3. There was no 
significant difference in hepatic total cholesterol concentrations between CETP-TG and 
non-TG mice. The addition of cholesterol to the MUF A diet caused a significant increase 
in hepatic total cholesterol concentrations for both CETP-TG and non-TG mice (2.25 
fold, p=0.006 and 2.13 fold, p=O.OOOO 1 increase respectively). Hepatic total 
triacylglycerol concentrations of CETP-TG were 1.53 fold higher {p=0.005) than non-TG 
mice when fed a diet enriched in MUF A. The addition of cholesterol to the MUF A diet 
caused a significant increase in hepatic total triacylglycerol concentrations in both CETP-
TG and non-TG mice (2.31 fold,p=0.007 and 1.56 fold,p=0.01 increase respectively). 
3.1.4 Plasma CETP activity and hepatic CETP mRNA levels 
The plasma CETP activity and hepatic CETP mRNA levels were measured for 
transgenic mice expressing CETP. Non-TG mice had undetectable CETP activity and 
mRNA levels. Addition of cholesterol to the MUF A diet caused significant inhibition of 
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Table 3.3: Hepatic lipid levels of CETP transgenic (CETP-TG) and non transgenic 
(NON-TG) mice fed a diet enriched in MUFA.1 
Group Diet n Total Total 
Cholesterol Triacylglycerol 
(mmoVmg liver) (mmol/mg liver) 
CETP-TG MUFA 4 7.82±1.67b 61.01 ±4.12bc 
MUFA + 8 17.59±4.34a 141.15 ±24.21 a 
cholesterol 
NON-TG MUFA 8 6.14±1.05b 39.80±4.53d 
MUFA + 5 13.10±1.31a 61.97± 11.24b 
cholesterol 
1 Values shown are mean ± standard deviation. Values without a common superscript are 
significantly different. (p < 0.05). 
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CETP activity (56% of mice fed the MUFA diet (p=0.04) (Figure 3.1). There is a parallel 
reduction in hepatic CETP mRNA expression in mice fed a MUF A diet with added 
cholesterol (Figure 3.2). 
3.1.5 Cholesterol 7a. hydroxylase (cyp7a) activity 
To investigate whether dietary cholesterol influences the breakdown of 
cholesterol in liver, the activity of cyp7a was measured. The cyp7a activity was 2.1 fold 
higher (p=0.0007) in CETP-TG mice compared to non-TG mice when fed a diet enriched 
in MUFA (Figure 3.3). The addition of cholesterol to the MUFA diet increased cyp7a 
activity in both non-TG and CETP-TG mice; however, the fold increase was greater for 
non-TG mice compared to CETP-TG mice (3.2 fold, p=0.003 increase vs. 2.4 fold, 
p=0.0005 increase). 
3.1.6 Summary of findings when mice were fed a diet rich in MUFA 
The expression of CETP gene decreases the plasma HDL-cholesterol and 
increases hepatic triacylglycerol and cyp7a activity. The addition of 1% cholesterol to the 
MUF A diet increased the LDL-cholesterol, hepatic total cholesterol, plasma 
triacylglycerol, and cyp7a activity regardless of the presence or absence of the CETP 
trans gene. Dietary cholesterol decreased plasma CETP activity and liver CETP mRNA 
levels in CETP-TG mice fed a diet enriched in MUF A. 
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Figure 3.1: Addition of cholesterol to a diet enriched in MUFA inhibits CETP 
activity. The CETP transgenic mice were fed a high fat diet enriched in MUFA (20% 
w/w) in the presence (n=8) or absence (n=4) of 1% cholesterol. Plasma was collected and 
assayed for CETP activity using the radioisotope method as explained in the methods 
section. Values shown are mean ± standard deviation. Differences between groups were 
evaluated using Student' s ttest. Differences were considered significant if p < 0.05 and 
marked with * if significant. 
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Figure 3.2: The addit ion of cholesterol to a diet enriched in MUFA inhibits CETP 
gene expression. The CETP transgenic mice were fed a high fat diet enriched in MUF A 
(20% w/w) in the presence (n=8) or absence (n=4) of 1% cholesterol. Total liver RNA 
was reverse transcribed and the eDNA template for CETP and GAPDH was amplified as 
described in methods. The amounts of amplified templates were quantitated and the 
abundance of CETP mRNA is expressed relative to GAPDH mRNA content. Values are 
mean± standard deviation. Differences between groups were evaluated using Student's t 
test. Differences were considered significant if p < 0.05 and marked with* if 
significant. 
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Figure 3.3: Dietary cholesterol increases cyp7a activity in CETP-TG and non-TG 
mice. The CETP transgenic (CETP-TG; solid bars) and non transgenic (NON-TG; open 
bars) mice were fed a diet enriched in MUFA (20% w/w) in the presence (MUFA +C) or 
absence (MUF A) of 1% cholesterol. Microsomes were prepared from liver samples and 
assayed for cyp7a activity as described in methods. Values shown are mean± standard 
deviation (CETP-TG, MUFA n=4; CETP-TG, MUFA+C n=8; non-TG, MUFA n=8; non-
TG, MUFA+C n=5). Differences between groups were tested using analysis of variance 
(ANOVA). Values without a common superscript are significantly different. (p < 0.05). 
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3.2 Effect of a high fat diet enriched in saturated fatty acids (SF A) on cholesterol 
metabolism 
3.2.1 Body weight and liver weight of mice fed SF A diet 
Body weights were recorded to ensure that mice were eating the experimental 
diets. The CETP-TG and non-TG mice fed SF A, with or without dietary cholesterol 
showed no significant differences in body weight over two week feeding period (Table 
3.4). There were no significant differences in liver weights in CETP-TG and non-TG 
mice fed SF A diet with or without dietary cholesterol. 
3.2.2 Plasma lipid levels 
Changes in plasma lipid levels of CETP-TG and non-TG mice fed a diet enriched 
in SFA with or without cholesterol are shown in Table 3.5. Total plasma cholesterol 
concentrations were not significantly different between the CETP-TG and non-TG mice 
fed a diet enriched in SF A. Addition of cholesterol to the SF A diet had no significant 
effect on the concentrations of total plasma cholesterol concentrations in both CETP-TG 
and non-TG mice. The LDL-cholesterol concentrations were not significantly different 
between CETP-TG and non-TG mice fed a diet enriched in SF A. Addition of cholesterol 
to the SFA diet caused a 1.35 (p=O.Ol) and 1.26 fold increase (p=0.006) in LDL-
cholesterol concentrations in CETP-TG and non-TG mice respectively. The HDL-
cholesterol concentrations of CETP-TG mice were lower compared to non-TG mice 
(66% of non-TG mice fed SFA diet, p =0.04). Addition of cholesterol to the SFA diet had 
no significant effect on the HDL-cholesterol concentrations in both CETP-TG and non-
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Table 3.4: Body weight and liver weight of CETP transgenic (CETP-TG) and non 
transgenic (NON-TG) mice fed SFA diet in the presence or absence of 1% 
cholesterol.1 
Group Diet n Original body Final body Liver 
weight (g) weight (g) weight (g) 
CETP-TG SFA 4 23.13±1.84 25.30± 1.87 1.38±0.07 
SFA+ 5 23.08±3.14 25.14±3.21 1.22±0.21 
cholesterol 
NON-TG SFA 5 23.05±2.98 24.05±2.88 1.21 ±0.20 
SFA+ 4 23.07±4.20 24.20±3.08 1.23±0.23 
cholesterol 
1 The mice were weighed at the beginning and conclusion of the experiment. The livers 
were collected and weighed at the conclusion of the experiment. Values shown are mean 
± standard deviation 
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Table 3.5: Plasma lipid levels of CETP transgenic (CETP-TG} and non transgenic 
(NON-TG) mice fed a diet enriched in SFA.1 
Group Diet n Total LDL- HDL- Total 
Cholesterol Cholesterol Cholesterol Triacylglycerol 
(mmol/L) (mmol/L) (mmol/L) (mmol/L) 
CETP- SFA 4 1.48±0.38a 0.57±0.03b 0.59±0.13b 0.61 ±0.23a 
TG 
SFA+ 5 1.61 ±0.42a 0.77±0.04a 0.57±0.12b 0.72±0.12a 
cholesterol 
NON- SFA 5 1.55±0.17a 0.61±0.02b 0.89±0.12a 0.64±0.1la 
TG 
SFA+ 4 2.00±0.42a 0.77±0.03a 0.84±0.12ab 0.71±0.29a 
cholesterol 
1 Values shown are mean ± standard deviation. Values without a common superscript are 
significantly different. (p < 0.05). 
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TG mice. Total plasma triacylglycerol concentrations were not significantly different 
between the CETP-TG and non-TG mice fed a diet enriched in SF A. Addition of 
cholesterol to the SF A diet had no significant effect on the concentrations of total plasma 
triacylglycerol in both CETP-TG and non-TG mice. 
3.2.3 Hepatic lipid levels 
Changes in hepatic lipid levels ofCETP-TG and non-TG mice fed a high fat diet 
enriched in SFA with or without cholesterol are shown in Table 3.6. There was no 
significant difference in the hepatic total cholesterol concentrations of CETP-TG and 
non-TG mice fed a diet enriched in SF A. The addition of cholesterol to the SF A diet 
caused a significant increase in hepatic total cholesterol concentration in both CETP-TG 
and non-TG mice (2.2 fold,p=O.Ol and 2 fold,p=O.OOl increase respectively). There was 
no significant difference in hepatic total triacylglycerol concentrations of CETP-TG and 
non-TG mice fed a diet enriched in SF A. Addition of cholesterol to the SF A diet had no 
significant effect on the hepatic total triacylglycerol concentrations in both CETP-TG and 
non-TG mice. 
3.2.4 Plasma CETP activity and hepatic CETP mRNA levels 
The CETP activity and mRNA expression was undetectable in non-TG mice, thus 
data is only presented for CETP-TG mice. The plasma CETP activity increased with the 
addition of cholesterol to the SFA diet (1.7 fold,p=0.02) (Figure 3.4). However, while 
the hepatic CETP mRNA expression shows a trend toward an increase, there is no 
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Table 3.6: Hepatic lipid levels of CETP transgenic (CETP-TG} and non transgenic 
(NON-TG} mice fed a diet enriched in SFA.1 
Group Diet n Total Total 
Cholesterol Triacylglycerol 
(mmol/mg liver) (mmol/mg liver) 
CETP-TG SFA 4 16.43±3.37b 7.19±2.47a 
SFA+ 5 35.27±6.93a 9.76±2.05a 
cholesterol 
NON-TG SFA 5 16.59±2.81 b 8.24±3.00a 
SFA + 4 34.07±3.76a 10.14±2.81a 
cholesterol 
1 Values shown are mean ± standard deviation. Values without a common superscript are 
significantly different. (p < 0.05). 
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Figure 3.4: Addition of cholesterol to a diet enriched in SF A increases CET P 
activity. The CETP transgenic mice were fed a high fat diet enriched in SF A (20% w/w) 
in the presence (n=5) or absence (n=4) of 1% cholesterol. Plasma was collected and 
assayed for CETP activity using the radioisotope method as explained in the methods 
section. Values shown are the mean ± standard deviation. Differences between groups 
were evaluated using Student's ttest. Differences were considered significant ifp < 0.05 
and marked with a * if significant. 
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significant change with the addition of cholesterol to the SF A diet (Figure 3 .5). 
3.2.5 Cholesterol 7a-hydroxylase (cyp7a) activity 
To investigate whether dietary cholesterol influences the breakdown of 
cholesterol in liver, the activity of cyp7a was measured. The cyp7a activity ofCETP-TG 
mice fed a diet enriched in SF A was significantly lower as compared to non-TG mice fed 
the SF A diet (70% of non-TG mice, p=0.03) (Figure 3.6). The addition of cholesterol to 
the SFA diet increased cyp7a activity in both non-TG and CETP-TG mice (2.2 fold, 
p=0.002 and 2 fold, p=0.000008 increase respectively). 
3.2.6 Summary of findings when mice were fed a diet rich in SFA 
The expression of CETP gene decreased plasma HDL-cholesterol levels in mice. 
The addition of cholesterol to the SF A diet had no effect on plasma LDL-cholesterol 
concentrations, whereas the hepatic total cholesterol concentration increased. The cyp7a 
activity decreased in mice expressing CETP, addition of cholesterol to the SF A diet 
increased cyp7a activity in both CETP-TG and non-TG mice. Dietary cholesterol 
increased plasma CETP activity in mice fed a diet enriched in SF A but there was no 
corresponding increase in liver CETP mRNA. 
3.3 Comparison of the effect of different dietary fats on CETP regulation 
The CETP activity of CETP-TG mice fed diets emiched in SF A are significantly 
higher than diets enriched in MUFA (1.7 fold,p=0.03) (Figure 3.7). The CETP activity of 
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Figure 3.5: The addition of cholesterol to a diet enriched in SFA has no significant 
effect on CET P mRNA abundance. The CETP transgenic mice were fed a high fat diet 
enriched in SF A (20% w/w) in the presence (n=5) or absence (n=4) of 1% cholesterol. 
Total liver RNA was reverse transcribed and the eDNA template for CETP and GAPDH 
was amplified as described in methods. The amounts of amplified templates were 
quantitated and the abundance of CETP mRNA is expressed relative to GAPDH mRNA 
content. Values are mean ± standard deviation. Differences between groups were 
evaluated using Student's t test. Differences were considered significant if p < 0.05. 
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Figure 3.6: Dietary cholesterol increases cyp7a activity in CETP-TG and non-TG 
mice. The CETP transgenic (CETP-TG; solid bars) and non transgenic (NON-TG; open 
bars) mice were fed a diet enriched in SFA (20% w/w) in the presence (SFA +C) or 
absence (SF A) of 1% cholesterol. Microsomes were prepared from liver samples and 
assayed for cyp7a activity as described in methods. Values shown are mean± standard 
deviation (CETP-TG, SFA n=4; CETP-TG, SFA+C n=5; non-TG, SFA n=5; non-TG, 
SFA+C n=4). Differences between groups were tested using analysis ofvariance 
(ANOVA). Values without a common superscript are significantly different. (p < 0.05). 
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Figure 3.7: Effect ofMUFA and SFA enriched diets in the presence or absence of 
cholesterol on CETP activity. The CETP transgenic mice were fed a high fat diet 
enriched in either MUFA or SFA (20% w/w) in the presence (MUFA+C, n=8; SFA+C, 
n=5) or absence of 1% cholesterol (MUFA, n=4; SFA, n=4). Plasma was collected and 
assayed for CETP activity using the radioisotope method as explained in the methods 
section. Values shown are mean ± standard deviation. Differences between groups were 
tested using analysis of variance (ANOV A). Values without a common superscript are 
significantly different. (p < 0.05). 
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CETP-TG mice fed a SF A diet with the addition of 1% cholesterol is significantly higher 
compared to mice fed a MUFA diet with the addition of 1% cholesterol (5 fold, 
p=0.0009). The CETP mRNA abundance of CETP-TG mice fed a MUF A enriched diet is 
significantly higher than that of mice fed the SPA emiched diet (1.8 fold,p=O.Ol)(Figure 
3.8). However, there is no difference in the CETP mRNA abundance ofCETP-TG mice 
fed MUF A and SF A diets when cholesterol is added to these diets. 
In summary, comparison of the CETP-TG mice fed different fat types show that 
the basal CETP activity is higher when the mice are fed a diet enriched in SF A compared 
to mice fed a diet enriched in MUF A. There was a different response to dietary 
cholesterol with the basal fat type, CETP activity decreased when cholesterol was added 
to the MUF A diet but increased when added to the SF A diet. CETP mRNA levels were 
lower in animals fed the SF A diet than those fed the MUF A diet. Addition of cholesterol 
to the MUF A diet decreased CETP mRNA levels but there was no significant change 
when cholesterol was added to the SPA diet. These results suggest that the effect of 
dietary cholesterol on CETP depends on the composition of the dietary fat (saturated or 
monounsaturated). The mechanism appears to involve, at least in part, changes in the 
liver CETP mRNA. This leads to the study of the transcriptional control of CETP using 
CETP gene constructs in cell culture. 
55 
a 
(I) 0.9 (.) 
c 
ro 0.8 "0 c 
::J 0.7 .0 
ro 
~ 0.6 
a:::: 0.5 E 
~ 0.4 
w () 0.3 
~ 0.2 ~ 
ro 
Q) 
a:::: 0.1 
0 
MUFA MUFA+C SFA SFA+C 
Figure 3.8: CETP mRNA abundance in CETP-TG mice fed diets enriched in 
various fatty acids in the presence or absence of dietary cholesterol. The CETP 
transgenic mice were fed a high fat diet enriched in either MUF A or SF A (20% w/w) in 
the presence (MUF A +C, n=8; SF A +C, n=5) or absence of 1% cholesterol (MUF A, n=4; 
SFA, n=4). Total liver RNA was reverse transcribed and the eDNA template for CETP 
and GAPDH was amplified as described in methods. The amounts of amplified templates 
were quantitated and the abundance of CETP mRNA is expressed relative to GAPDH 
mRNA content. Values are mean± standard deviation. Differences between groups were 
tested using analysis of variance (ANOVA). Values without a common superscript are 
significantly different. (p < 0.05). 
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3.4 Mechanism of the human CETP gene regulation by fatty acids and 
cholesterol 
3.4.1 The SW 872 cell line and CETP regulation 
SW 872 cells, a human liposarcoma cell line, have previously been shown to 
synthesize and secrete CETP when grown in the presence of insulin and oleic acid 
(Richardson eta/., 1996). Addition ofLDL cholesterol and 25-0H cholesterol increased 
the CETP activity and mRNA abundance in the SW 872 cells (Richardson eta/., 1996; 
Gauthier eta/., 1999). These findings suggest that SW 872 cells might be an appropriate 
cell line to study the regulation of CETP. 
The morphology of SW 872 cells changed when grown in the presence of insulin 
and oleic acid for 48 hours. The cells appeared to be round as opposed to spindle shaped 
and fibroblast like. To investigate whether SW 872 cells accumulate lipids when grown 
in the presence of insulin and oleic acid, the cells were grown in differentiation medium 
and regular growth medium for 48 hours and stained with oil red 0 (Figure 3.9). The 
SW 872 cells grown in the presence of differentiation medium show greater lipid 
accumulation as judged by the red staining (Panel B) compared to the cells grown in 
regular growth medium (Panel A). Lipids were extracted from SW 872 cells grown in 
regular and differentiation medium, at different time points. Triacylglycerol and 
cholesterol accumulation increased when the cells are grown in the presence of 
differentiation medium compared to cells grown in regular growth medium (Figure 3.1 0 
and 3.11 respectively). 
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Figure 3.9: Oleic acid and insulin cause lipid accumulation in SW 872 cells. SW 872 
cells were grown to 70% confluency in regular growth media. Growth media was then 
replaced by regular growth medium without FBS (control) or differentiation media 
(differentiated) for 48 h. At 48h, the cells were stained with Oil Red 0 as described in 
methods section. 
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Figure 3.10: Oleic acid and insulin cause triglyceride accumulation in SW 872 cells. 
SW 872 cells were grown to 70% confluency in regular growth medium. Growth media 
was then replaced by differentiation media (differentiated, •) or regular growth medium 
without FBS (control, +) on day 0. Lipids were extracted and assayed for triglyceride 
concentration at 0, 2, 4 and 6 days. Results shown represent the mean ± standard 
deviation. 
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Figure 3.11: Oleic acid and insulin cause cholesterol accumulation in SW 872 cells. 
SW 872 cells were grown to 70% confluency in regular growth medium. Growth media 
was then replaced by differentiation media (differentiated, • ) or regular growth medium 
without FBS (control, • ) on day 0. Lipids were extracted and assayed for cholesterol 
concentration at 0, 2, 4 and 6 days. Results shown represent the mean ± standard 
deviation. 
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3.4.2 Expression of CETP.CAT gene chimeras in SW 872 cells requires 
cotransfection of C/EBP a 
Chimeric gene constructs harbouring sequential deletions of the human CETP 
gene promoter linked to CAT as a reporter (150CETP.CAT, 650CETP.CAT, 
3200CETP.CAT) were transfected into SW 872 cells that had been grown in 
differentiation medium for 24 hours. Cells were cotransfected with P-galactosidase as a 
control for transfection efficiency. CETP expression was extremely low under these 
conditions (Figure 3 .12; Panel A) as judged by the CAT activity. Since C/EBP a is 
known to increase the expression ofCETP (Agellon et al., 1992), we cotransfected the 
C/EBPa expression vector along with the CETP chimeric gene constructs (Figure 3.12, 
Panel A). Cotransfection of the C/EBP a expression vector significantly increased the 
expression of lSOCETP.CAT and 650CETP.CAT (4.5 fold,p=0.04 and 3.3 foldp=0.007 
increase respectively) but had little effect on the expression of3200CETP.CAT (Figure 
3.12, Panel B). As C/EBPa was found to be required for CETP expression in SW 872 
cells, C/EBPa was cotransfected with the CETP.CAT gene constructs in all further 
experiments 
3.4.3 Regulation of the human CETP gene by 25-0H cholesterol is via 
LXRa/RXRa 
Cholesterol mediated stimulation of the CETP gene is via LXRa!RXRa and is 
contained within 400 bp of the promoter region (Luo et al. , 2000). To confirm these 
previous findings in SW 872 cells, differentiated SW 872 cells were transfected with 
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Figure 3.12: The expression of CETP is enhanced by coexpressing C/EBPa.. The 
CETP.CAT gene chimeras (panel A; panel B, open bars) or CETP.CAT gene chimeras 
and a plasmid encoding C/EBPa (panel A; panel B, solid bars) were cotransfected into 
differentiated SW 872 cells. The CAT activity was normalized to the P-galactosidase 
activity encoded by the p-galactosidase expression vector. The normalized CAT activity 
in the control cells was assigned a value of one. Results shown represent the mean± 
standard deviation of three independent experiments. Differences were evaluated using 
the Student's t test. Differences were considered significant if p < 0.05 and marked with * 
if significant. 
62 
CETP chimeric gene constructs along with LXRa and RXRa. expression vectors and P-
galactosidase (Figure 3.13). The transfected cells were treated with 4 f.!g/ml of 25-0H 
cholesterol. The expression of650CETP.CAT was increased 3.3 fold (p:S0.002) when 
25-0H cholesterol was added to the growth media. There was no significant effect on the 
expression of 150CETP.CAT or 3200CETP.CAT by the addition of25-0H cholesterol. 
This cholesterol mediated induction was not observed in cells when LXRa and RXRa is 
not cotransfected along with the CETP chimeric gene constructs (data not shown). These 
findings are similar to the previous observations by Luo et al. (2000) suggesting that the 
cholesterol mediated induction of CETP by LXRaiRXRa is contained within 650 bp of 
the promoter. 
3.4.4 Effect of oleic acid on the regulation of human CETP gene expression 
Oleic acid at a concentration of 50 f.!M had no effect on the expression of 
150CETP.CAT, 650CETP.CAT, and 3200CETP.CAT when the differentiated SW 872 
cells are transfected with CETP chimeric gene constructs and P-galactosidase only 
(Figure 3.14). Fatty acids regulate gene expression of various enzymes via PP ARaiRXRa. 
Thus, we co-expressed PP ARa and RXRa along with the CETP chimeric gene constructs 
in differentiated SW 872 cells to investigate whether expression of PP ARa and RXRa 
mediates the regulation of CETP by fatty acids. Treatment of differentiated SW 872 cells 
with 50f.!M oleic acid resulted in a 1.4 fold increase (p=0.006) in the expression of 
650CETP.CAT (Figure 3.15). However, there was no significant change in the 
expression of 150CETP.CAT and 3200CETP.CAT. This suggests that 
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Figure 3.13: Regulation of CETP gene by 25-0H cholesterol via LXRa/RXRa.. The 
CETP.CAT gene chimeras and plasmids encoding C/EBPa LXR.aand RXR.a were 
cotransfected into differentiated SW 872 cells. 25-0H cholesterol was added to the 
culture medium to a final concentration of 4 J.lg/ml (solid bars). Control cells received 
DMSO alone (open bars). The CAT activity was normalized to the p-galactosidase 
activity encoded by the p-galactosidase expression vector. The normalized CAT activity 
in the control cells was assigned a value of one. Results shown represent the mean± 
standard deviation of three independent experiments. Differences were evaluated using 
the Student's t test. Differences were considered significant ifp < 0.05 and marked with* 
if significant. 
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Figure 3.14: Regulation of human CETP gene by oleic acid. The CETP.CAT gene 
chimeras and a plasmid encoding C/EBP a were cotransfected into differentiated SW 872 
cells. Oleic acid (18:1) complexed to fatty acid free BSA was added to the culture 
medium to a final concentration of 50 J.!M (solid bars). Control cells received BSA alone 
(open bars). The CAT activity was normalized to the p-galactosidase activity encoded by 
the p-galactosidase expression vector. The normalized CAT activity in the control cells 
was assigned a value of one. Results shown represent the mean ± standard deviation of 
three independent experiments. Differences were evaluated using the Student' s t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
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Figure 3.15: The regulation of CETP gene by oleic acid is mediated via 
PPARa./RXRa. The CETP.CAT gene chimeras and plasmids encoding C/EBPa, PPARa 
and RXRa were cotransfected into differentiated SW 872 cells. Oleic acid (18:1) 
complexed to fatty acid free BSA was added to the culture medium to a final 
concentration of 50 )lM (solid bars). Control cells received BSA alone (open bars). The 
CAT activity was normalized to the P-galactosidase activity encoded by the P-
galactosidase expression vector. The normalized CAT activity in the control cells was 
assigned a value of one. Results shown represent the mean± standard deviation of three 
independent experiments. Differences were evaluated using the Student's t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
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PP ARaiRXRa mediates the effect of oleic acid on the CETP gene expression and this 
interaction occurs within the -650 bp region of the 5' regulatory region. 
As oleic acid and cholesterol regulate the human CETP gene independently when 
cotransfected with PP ARaiRXRa or LXRa/RXRa, we further investigated whether 
cholesterol and fatty acids given in combination have a similar effect on CETP gene 
expression. When SW 872 cells are cotransfected with PP ARa and RXRa and treated 
with 4 ).lg/ml of25-0H cholesterol and 50j..tM oleic acid together, there was a significant 
increase in the expression of3200CETP.CAT and 650CETP.CAT (Figure 3.16). 
However, there was no significant effect on the expression of 150CETP.CAT. On the 
other hand, when SW 872 cells were cotransfected with LXRx. and RXR.a and treated 
with 4 J.lg/ml of25-0H cholesterol and 50 j..tM oleic acid, there was a significant decrease 
in the expression of 150CETP.CAT (54% of the control,p=0.006), and a significant 
increase in the expression of650CETP.CAT (3.2 fold,p=0.02) and 3200CETP.CAT (2.5 
fold, p=0.04) (Figure 3.17). 
Next, we co-transfected the CETP.CAT gene chimeras with PPARa, RXR.a and 
LXRx. and treated the cells with oleic acid and cholesterol to investigated whether these 
transcription factors interact to mediate the regulation of CETP. The addition of 50 11M 
oleic acid and 4 11g/mL 25-0H cholesterol to differentiated SW 872 cells coexpressing 
LXRa., PP ARa, and RXRa decreased the expression of 150CETP.CAT (83% of control, 
p=0.02) but increased the expression of3200CETP.CAT (1.7 fold, p =0.03) (Figure 3.18) 
with no significant effect on 650CETP.CAT expression. 
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Figure 3.16: Regulation of CETP gene by oleic acid and 25-0H cholesterol via 
PPARa./RXRu. The CETP.CAT gene chimeras and plasmids encoding C/EBPa., 
PPARa. and RXRa. were cotransfected into differentiated SW 872 cells. Oleic acid (18:1) 
complexed to fatty acid free BSA was added to the culture medium to a final 
concentration of 50 !J.M and 25-0H cholesterol was added to the culture medium to a 
final concentration of 4 IJ.g/ml (solid bars). Control cells received vehicle alone (open 
bars). The CAT activity was normalized to the p-galactosidase activity encoded by the P-
galactosidase expression vector. The normalized CAT activity in the control cells was 
assigned a value of one. Results shown represent the mean ± standard deviation of three 
independent experiments. Differences were evaluated using the Student's t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
68 
5 
* ~4 
* ·::; 
.. 
u 
<( 3 
~ (.) 
Q) 
> 2 ~ 
Q) 
0::: 1 
0 
150CETP.CAT 650CETP.CAT 3200CETP.CAT 
Figure 3.17: Regulation of CETP gene by oleic acid and 25-0H cholesterol via 
LXRa/RXRa.. The CETP.CAT gene chimeras and plasmids encoding C/EBPa., LXRx 
and RXRx were cotransfected into differentiated SW 872 cells. Oleic acid (18: 1) 
complexed to fatty acid free BSA was added to the culture medium to a final 
concentration of 50 j.tM and 25-0H cholesterol was added to the culture medium to a 
final concentration of 4 j.tg/ml (solid bars). Control cells received vehicle alone (open 
bars). The CAT activity was normalized to the P-galactosidase activity encoded by the P-
galactosidase expression vector. The normalized CAT activity in the control cells was 
assigned a value of one. Results shown represent the mean ± standard deviation of three 
independent experiments. Differences were evaluated using the Student's t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
69 
2.5 
* 
Z' 2 
·:; 
;.-::; 
!;}_ 1.5 ~ 
0 
* ~ 
~ 
1 
Q) 
0::: 0.5 
0 
150CETP.CAT 650CETP.CAT 3200CETP.CAT 
Figure 3.18: Regulation of CETP gene by oleic acid and 25-0H cholesterol via 
PPARa.IRXRa./LXRa.. The CETP.CAT gene chimeras and plasmids encoding C/EBPa, 
PP ARa., LXRa and RXRa were cotransfected into differentiated SW 872 cells. Oleic acid 
(18:1) complexed to fatty acid free BSA was added to the culture medium to a final 
concentration of 50 !J.M and 25-0H cholesterol was adged to the culture medium to a 
final concentration of 4 !J.g/mL (solid bars). Control cells received vehicle alone (open 
bars). The CAT activity was normalized to the P-galactosidase activity encoded by the P-
galactosidase expression vector. The normalized CAT activity in the control cells was 
assigned a value of one. Results shown represent the mean ± standard deviation of three 
independent experiments. Differences were evaluated using the Student's t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
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3.4.5 Effect of stearic acid on the regulation of human CETP gene expression 
Treatment of differentiated SW 872 cells with 50 !J.M stearic acid (18:0) inhibited 
the expression of650CETP.CAT when PPARa and RXRa are coexpressed along with 
CETP. CAT gene chimeras (Figure 3 .19). However, there was no significant change in the 
expression of 150CETP.CAT and 3200CETP.CAT. 
Next, stearic acid and cholesterol were added in combination to differentiated 
SW 872 cells to study their combined effect. The addition of 4 1-1g/ml 25-0H cholesterol 
and 50 !J.M stearic acid to differentiated SW 872 cells coexpressing PP ARa and RXRa 
caused a decrease in the expression of 150CETP.CAT and 650CETP CAT (Figure 3.20). 
However, there was no significant change in 3200CETP.CAT expression. 
The addition of 4 j..!g/ml of 25-0H cholesterol and 50 !J.M stearic acid to growth 
media of differentiated SW 872 cells co-expressing LXRa and RXR.a caused an ~50% 
(p=0.03) decrease in the expression of3200CETP.CAT (Figure 3.21). However, it had no 
effect on the expression of 150CETP.CAT and 650CETP.CAT. 
Next, we cotransfected the SW 872 cells with PPARa, RXR.a and LXRa to 
investigate whether these transcription factors interact to mediate the effects of stearic 
acid and cholesterol on CETP gene regulation. The addition of 50 1-1M stearic acid and 
4 !J.g/mL 25-0H cholesterol to differentiated SW 872 cells decrease the expression of 
150CETP.CAT and 650CETP.CAT (20% ofcontrol,p=0.003; 51% ofcontrol, p=0.01 
respectively) but had no effect on 3200CETP.CAT expression (Figure 3.22). 
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Figure 3.19: Regulation ofCETP gene by stearic acid via PPARa/RXRa. The 
CETP. CAT gene chimeras and plasmids encoding C/EBP a, PP ARa, and RXRa were 
cotransfected into differentiated SW 872 cells. Stearic acid was added to the culture 
medium to a final concentration of 50 !-lM (solid bars). Control cells received BSA alone 
(open bars). The CAT activity was normalized to the ~-galactosidase activity encoded by 
the ~-galactosidase expression vector. The normalized CAT activity in the control cells 
was assigned a value of one. Results shown represent the mean ± standard deviation of 
three independent experiments. Differences were evaluated using the Student's t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
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Figure 3.20: Regulation of the CETP gene by stearic acid and 25-0H cholesterol 
mediated via PPARafRXRa. The CETP.CAT gene chimeras and plasmids encoding 
C/EBP a, PP ARa., and RXRa. were cotransfected into differentiated SW 872 cells. Stearic 
acid (18:0) complexed to fatty acid free BSA was added to the culture medium to a final 
concentration of 50 J.!M, and 25-0H cholesterol was added to the culture medium to a 
final concentration of 4 J.!glml (solid bars). Control cells received the vehicle alone (open 
bars). The CAT activity was normalized to the P-galactosidase activity encoded by the P-
galactosidase expression vector. The normalized CAT activity in the control cells was 
assigned a value of one. Results shown represent the mean± standard deviation of three 
independent experiments. Differences were evaluated using the Student's t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
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Figure 3.21: Regulation of CETP gene by stearic acid and 25-0H cholesterol via 
LXRa/RXRa. The CETP.CAT gene chimeras and plasmids encoding C/EBPa., 
LXRu, and RXRa were cotransfected into differentiated SW 872 cells. Stearic acid 
(18:0) complexed to fatty acid free BSA was added to the culture medium to a final 
concentration of 50 !lM and 25-0H cholesterol was added to the culture medium to a 
final concentration of 4 llg/ml (solid bars). Control cells received the vehicle alone (open 
bars). The CAT activity was normalized to the P-galactosidase activity encoded by the P-
galactosidase expression vector. The normalized CAT activity in the control cells was 
assigned a value of one. Results shown represent the mean ± standard deviation of three 
independent experiments. Differences were evaluated using the Student' s t test. 
Differences were considered significant if p < 0.05 and marked with * if significant. 
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Figure 3.22: Regulation of the CETP gene by stearic acid and 25-0H cholesterol 
mediated via PPARa/RXRa./LXRa. The CETP.CAT gene chimeras and plasmids 
encoding C/EBP a, LXRa, PP ARa and RXRa were cotransfected into differentiated SW 
872 cells. Stearic acid (18:0) complexed to fatty acid free BSA was added to the culture 
medium to a final concentration of 50 J.!M and 25-0H cholesterol was added to the 
culture medium to a final concentration of 4 Jlg/mL (solid bars). Control cells received 
vehicle alone (open bars). The CAT activity was normalized to the p-galactosidase 
activity encoded by the P-galactosidase expression vector. The normalized CAT activity 
in the control cells was assigned a value of one. Results shown represent the mean ± 
standard deviation of three independent experiments. Differences were evaluated using 
the Student's t test. Differences were considered significant ifp < 0.05 and marked with* 
if significant. 
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Chapter 4: Discussion 
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4.1 Effect of a high fat diet enriched in MUFA on cholesterol metabolism 
4.1.1 Plasma lipid concentrations 
The plasma total cholesterol concentrations of CETP-TG mice were significantly 
lower than those ofthe non-TG mice fed a diet enriched in MUFA (Table 3.2). A similar 
decrease in total plasma cholesterol was seen in CETP-TG mice with the CETP gene 
under control of the mouse metallothionein-I promoter, compared to non-TG mice fed a 
chow diet and a high fat diet (Agellon eta!., 1991). This decrease was also seen in other 
studies where the CETP gene was under the control of its NFR in CETP-TG mice fed a 
chow diet (Masucci-Magoulas eta!., 1996; Foger eta!. , 1999). The decrease in plasma 
total cholesterol is due to a decrease in HDL-cholesterol caused by CETP transferring 
cholesterol esters from HDL-cholesterol to LDL- and VLDL-cholesterol. The addition of 
cholesterol to the MUF A enriched diet had no significant effect on total plasma 
cholesterol concentrations of CETP-TG and non-TG mice (Table 3.2). Feeding a 
cholesterol enriched diet to C57BL/6 mice has previously been shown not to have an 
effect on total plasma cholesterol concentrations (Schwartz et al. 2001). The response of 
different individuals and different species to dietary cholesterol varies widely due to 
several reasons (Beynen et al., 1987). One possibility is increased breakdown of 
cholesterol to bile acids via cyp7a, which is induced by dietary cholesterol (Russell et al., 
1992). The addition of cholesterol to MUFA diet was found to induce cyp7a activity in 
CETP-TG and non-TG mice. Thus it is likely that increased breakdown of cholesterol to 
bile acids in mice fed dietary cholesterol prevents an increase in plasma total cholesterol 
concentrations. 
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There was no difference in LDL-cholesterol concentrations between CETP-TG 
and non-TG mice fed a MUFA enriched diet (Table 3.2). The VLDL+LDL-cholesterol in 
CETP-TG and non-TG mice were also not found to be significantly different when fed a 
chow diet or a high fat diet (Agellon et al., 1991). However, they found a decrease in the 
ratio of free cholesterol to cholesterol ester in all lipoprotein fractions of CETP-TG mice 
suggesting an increase in LCAT activity to replace cholesterol ester transferred out of 
HDL into the apo-B lipoproteins. The addition of cholesterol to the MUF A enriched diet 
caused an increase in LDL-cholesterol concentrations in CETP-TG and non-TG mice 
(Table 3.2). The increase in LDL-cholesterol with the addition of cholesterol to the diet is 
expected as a high fat, high cholesterol diet is known to increase LDL+VLDL-cholesterol 
in C57/BL6 mice (LeBoeuf et al., 1990). 
HDL-cholesterol was lower in CETP-TG mice compared to the non-TG mice 
when fed a MUF A-enriched diet (Table 3.2). The decrease in HDL-cholesterol is the 
result of CETP transferring cholesterol esters from HDL-cholesterol to LDL- and VLDL-
cholesterol (Agellon et al. 1991; Foger et al., 1999; Kawano et al., 2000). The addition of 
cholesterol to the MUF A diet had no effect on HDL-cholesterol concentrations in CETP-
TG and non-TG mice (Table 3.2). This is likely due to short term feeding of cholesterol 
(two weeks) since most studies observed changes in HDL-cholesterol by dietary 
cholesterol after four or more weeks (Kurushima et al., 1995a; Foger et al. , 1999). In fact 
CETP-TG and C57BL/6 mice fed a high fat, high cholesterol (1%) diet for 28 weeks 
showed an increased in HDL-cholesterol that gradually increased during the course of the 
feeding study (Marotti et al., 1993). 
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Total plasma triacylglycerol concentrations were not significantly different 
between the CETP-TG and non-TG mice (Table 3.2). CETP transfers triacylglycerol 
from LDL and VLDL to HDL, but does not affect the total concentration of 
triacylglycerol in plasma (Chang et al., 2001; Foger et al., 1999). 
4.1.2 Hepatic lipid concentrations 
Hepatic total cholesterol concentrations between CETP-TG and non-TG mice 
when fed a MUF A enriched diet were not significantly different (Table 3.3). However, 
Chang eta!. (200 1) found an increase in hepatic total cholesterol in CETP-TG mice with 
the human CETP gene under the control of the apolipoprotein AI promoter compared to 
non-TG mice when fed a MUF A enriched diet for five weeks. Our results show a trend 
towards an increase but the increase was not significant. The addition of cholesterol to 
the MUF A diet caused a significant increase in hepatic total cholesterol concentrations 
for both CETP-TG and non-TG mice (Table 3.3). These results indicate that dietary 
cholesterol is absorbed and delivered to the liver. 
Hepatic total triacylglycerol concentrations of CETP-TG mice were higher than 
non-TG mice when fed a diet enriched in MUFA (Table 3.3). The addition of cholesterol 
to the MUF A diet caused an increase in hepatic total triacylglycerol concentrations for 
both CETP-TG and non-TG mice (Table 3.3). This increase might be due to increased 
hepatic biosynthesis of triacylglycerol or decreased fatty acid oxidation (Fungwe et al., 
1993) and needs to be explored in future studies. 
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4.1.3 Plasma CETP activity and hepatic mRNA concentration 
Plasma CETP activity (Figure 3.1) and hepatic CETP mRNA expression (Figure 
3.2) decreased in CETP-TG mice when cholesterol was added to a diet enriched in 
MUF A. This differs from previous observations where addition of cholesterol to a high 
fat diet enriched with coconut oil, rich in 16:0 fatty acids, increased CETP mRNA and 
CETP activity in CETP-TG mice (Jiang et al., 1992). However, Kurushima et al (1995a) 
found that addition of 5% oleic acid to a cholesterol supplemented diet in hamsters 
prevents cholesterol induced increase in CETP activity, whereas palmitic acid increased 
CETP activity (Kurushima et al., 1995b ). These findings support our results suggesting 
that oleic acid interferes with the cholesterol mediated induction of CETP activity and 
gene expressiOn. 
4.1.4 Cholesterol ?a-hydroxylase (cyp7a) activity 
As addition of cholesterol to the MUF A diet was found to inhibit CETP activity, 
we used cyp7a activity that is known to be induced by dietary cholesterol as a positive 
control to ensure the mice were responding to dietary cholesterol. Moreover, the CETP 
and cyp7a promoters have similar sterol dependent induction by LXR and LRH, thus the 
expression ofCETP and cyp7a may be coordinately regulated in the liver (Luo et al. 
2001). 
The cyp7a activity was higher in CETP-TG mice compared to non-TG mice when 
both species were fed a diet enriched in MUFA (Figure 3.3). CETP expression may 
increase reverse cholesterol transport delivering more cholesterol to the liver, which 
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increases cyp7a activity. The addition of cholesterol to the MUF A diet increased cyp7a 
activity in both non-TG and CETP-TG mice (Figure 3.3) suggesting that the mice are 
responding to dietary cholesterol as expected. 
4.2 Effect of a high fat diet enriched in SFA on cholesterol metabolism 
4.2.1 Plasma lipid concentrations 
There was no difference between total plasma cholesterol concentrations in the 
CETP-TG and non-TG mice fed a diet enriched in SFA (Table 3.5). Previous studies by 
Agellon eta!. (1991) and our data on CETP-TG mice fed the MUFA diet showed a 
decrease in plasma total cholesterol concentrations when compared to non-TG mice, and 
this decrease was mainly due to a decrease in HDL-cholesterol concentrations. Chang et 
al. (2001) found no difference in the total plasma cholesterol concentrations of transgenic 
mice expressing human CETP, where the CETP gene is linked to the apolipoprotein A-1 
promoter and non-TG mice fed diets enriched in SF A. The absence of the total plasma 
cholesterol lowering effect in CETP-TG mice fed a SF A diet compared to those fed a 
MUFA and PUFA diet could be the result ofthe SF A's inability to maintain hepatic LDL 
receptor activity (Chang et al., 2001; Bucci et al., 1998). 
The addition of cholesterol to the SF A diet had no significant effect on the total 
plasma cholesterol concentrations in both CETP-TG and non-TG mice (Table 3.5). On 
the other hand, the LDL-cholesterol concentrations were significantly increased when 
cholesterol was added to the SF A diet for both CETP-TG and non-TG mice. The increase 
in LDL-cholesterol with the addition of cholesterol to the diet is expected as dietary 
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cholesterol is known to increase LDL+VLDL-cholesterol (Grundy et al., 1990; LeBoeuf 
et al., 1990). 
Total plasma triacylglycerol concentrations were not significantly different 
between the CETP-TG and non-TG mice fed a diet enriched in SFA (Table 3.5). We had 
similar observations when CETP-TG and non-TG mice were fed a diet enriched in 
MUFA (Table 3.2). The addition of cholesterol to the SFA diet had no significant effect 
on the concentrations of total plasma triacylglycerol in CETP-TG and non-TG mice 
(Table 3.5), similar to the observations made for the CETP-TG and non-TG mice fed the 
MUFA diet (Table 3.2). 
4.2.2 Hepatic lipid concentrations 
Hepatic total cholesterol concentrations of CETP-TG and non-TG mice when fed 
a diet enriched in SPA were not significantly different (Table 3.6). No difference was 
observed in hepatic total cholesterol between CETP-TG and non-TG mice when fed a 
diet enriched in MUFA (Table 3.3). The addition of cholesterol to the SPA diet caused a 
significant increase in hepatic total cholesterol concentration for both CETP-TG and non-
TG mice (Table 3.6), similar to the findings when these animals were fed a diet enriched 
in MUF A, indicating that dietary cholesterol is absorbed and delivered to the liver. 
Hepatic total triacylglycerol concentrations of CETP-TG and non-TG mice were 
not different when fed a SFA enriched diet (Table 3.6). The addition of cholesterol to the 
SF A diet had no significant effect on the concentrations of hepatic total triacylglycerol in 
both CETP-TG and non-TG mice. These results differ from the MUF A study where 
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CETP-TG mice had higher hepatic total triacylglycerol concentrations than non-TG mice, 
and the addition of cholesterol caused an increase in hepatic total triacylglycerol 
concentrations for both CETP-TG and non-TG mice (Table 3 .3). It is possible that mice 
like hamsters fed a SF A diet with supplemented cholesterol package more 
triacylglycerols into VLDL that is secreted from the liver (Fungwe et al., 1994). We did 
not measure VLDL concentrations in these mice; however, there was a significant 
increase in LDL-cholesterol concentrations which might be as a result of an increase in 
VLDL. 
4.2.3 Plasma CETP activity and hepatic CETP mRNA levels 
Plasma CETP activity increased when cholesterol was added to the SF A diet 
(Figure 3.4). The hepatic CETP mRNA levels showed a trend towards an increase but the 
effect was not significant (Figure 3.5). This differs from the MUFA diet study where a 
significant decrease in CETP activity and hepatic CETP mRNA expression was seen with 
the addition of dietary cholesterol. Previous reports indicate an increase in CETP activity 
and mRNA abundance with the addition of dietary cholesterol. The effect is further 
enhanced when cholesterol is added to a diet rich in saturated fatty acids (Jiang et at. 
1992). We found no significant increase in hepatic mRNA levels with the addition of 
cholesterol to the SF A diet, thus the increase in plasma CETP activity might be due to an 
increase in CETP secretion. 
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4.2.4 Cholesterol 7a hydroxylase (cyp7a) activity 
Dietary cholesterol is known to raise the cyp7a activity (Russell et al., 1992). We 
measured the cyp7a activity in CETP-TG and non-TG mice to ensure that the mice are 
responding to dietary cholesterol and to further investigate whether there is coordinated 
regulation of cyp7a and CETP. The addition of cholesterol to the SPA diet increased 
cyp7a activity in both non-TG and CETP-TG mice (Figure 3.6) confirming the response 
of cyp7a to dietary cholesterol. 
The cyp7a activity is lower in CETP-TG mice compared to the non-TG mice fed 
SF A alone or with added cholesterol. These fmdings are different from mice fed the 
MUFA diet where CETP-TG mice showed higher cyp7a activity suggesting that more 
cholesterol is returned to the liver via reverse cholesterol transport. Feeding diets 
enriched in saturated fatty acids are known to inhibit LDL-receptors (Bucci et al., 1992), 
thus under these conditions cholesterol might not be returned to the liver as efficiently. 
Kurushima et al., (1995b) found higher CETP activity in hamsters fed a diet enriched in 
SPA compared to a diet enriched in MUFA. However, the cyp7a activity was lower in 
SPA fed animals similar to our observations. Thus, CETP and cyp7a might not be 
coordinately regulated under certain dietary conditions. 
4.3 Mechanisms of the regulation of the human CETP gene by fatty acids and 
cholesterol 
The hepatic CETP mRNA expression of CETP-TG mice fed the MUF A enriched 
diet was significantly higher than mice fed the SF A enriched diet, indicating that the type 
84 
of fat itself has significant effect on the regulation ofCETP gene expression (Figure 3.8). 
The following sections deal with the molecular mechanisms involved in fatty acid and 
cholesterol mediated regulation ofCETP. 
4.3.1 Lipid accumulation in SW 872 cells 
The SW 872 cells were chosen to study CETP gene regulation as this cell line 
synthesizes and secretes CETP (Richardson et al., 1996), and expresses the necessary 
factors for CETP regulation by cholesterol and fatty acids (Richardson et al., 1996; 
Gauthier et al., 1999; Izem et al., 2001). The addition of insulin and oleic acid to the 
growth medium increases CETP synthesis and secretion in SW 872 cells (Richardson et 
al., 1996). When we grew these cells in the presence of 100 j.lg/ml fatty acid free BSA/ 
oleic acid, 1 j.lg/ml insulin, and 1 j.lg/ml transferrin, the morphology of the cells changed 
by 48 hours, the cells appeared enlarged and rounded as opposed to spindle shaped. 
Staining the cells with oil red 0 indicated lipid accumulation in these cells (Figure 3.9). 
The triacylglycerol and cholesterol concentrations increased significantly over a six day 
time period (Figure 3.10; Figure 3.11). A recent study by Izem et al. (2001) found that 
addition of oleate to the growth medium of SW872 cells caused rapid accumulation of 
triglyceride-containing droplets as demonstrated by oil red 0 staining, and also increased 
the CETP activity and mRNA levels. These observations suggest that the CETP 
biosynthesis and the cellular lipid pool are tightly linked. 
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4.3.2 Expression of CETP.CAT gene chimeras in SW 872 cells requires 
cotransfection of C/EBP a 
To understand the molecular mechanisms involved in CETP regulation by fatty 
acids and cholesterol, we used CETP chimeric gene constructs harbouring sequential 
deletions of the promoter region linked to CAT as a reporter (150CETP.CAT, 
650CETP.CAT, 3200CETP.CAT). These constructs were transfected into differentiated 
SW 872 cells; however, the expression, as indicated by the CAT activity, was very low 
(Figure 3.12A). C/EBPa is required to activate the human CETP promoter by binding to 
the -250 to -200 bp region (Agellon eta!., 1992). Cotransfection of the 
C/EBPa expression vector significantly increased the expression of 150CETP.CAT and 
650CETP.CAT but had little effect on the expression of3200CETP.CAT (Figure 3.12B). 
These results indicate that C/EBPa enhances the expression of 150CETP.CAT and 
650CETP.CAT, whereas 3200CETP.CAT is already expressed to the maximum. 
4.3.3 Regulation of the human CETP gene by 25-0H cholesterol is via 
LXRa!RXRa 
The cholesterol mediated induction of the CETP gene is known to involve 
LXRa!RXRx and this effect is contained within 400 bp of the promoter region (Luo et al., 
2000). These previous studies were carried out using 3T3-Ll cells. To confirm these 
findings in SW 872 cells, we transfected the CETP.CAT gene chimeras along with 
expression vectors for LXRa!RXRx and treated the transfected cells with 25-0H 
cholesterol. The expression of650CETP.CAT increased 3.3 fold when 25-0H 
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cholesterol was added to the growth media; however, there was no effect on the 
expression of 150CETP.CAT or 3200CETP.CAT (Figure 3.13). These results confirm the 
previous findings that cholesterol mediated regulation of the CETP gene is contained 
within 650 bp of the promoter region and requires LXRa!R.XRa.. 
4.3.4 Regulation of the human CETP chimeric gene constructs by oleic acid 
Fatty acids regulate the gene expression of various enzymes via the transcription 
factors PP ARa!R.XRa. (lssemann et al., 1990). Oleic acid had no effect on CETP gene 
regulation when PP ARa and RXRa were not coexpressed along with the CETP chimeric 
gene constructs (Figure 3.14). However, when PPARa/RXRa were coexpressed with 
CETP chimeric gene constructs, the expression of650CETP.CAT was significantly 
increased with no change in the expression of 150CETP.CAT and 3200CETP.CAT 
(Figure 3 .15). This suggests that PP ARa/RXRa mediates the regulation of CETP gene by 
fatty acids and this interaction occurs within the -650 bp region of the CETP gene 5' 
regulatory region. 
Since both oleic acid and cholesterol independently regulate the CETP gene via 
PP ARa!R.XRa. and LXRa/RXRa respectively, we further investigated whether fatty acids 
and cholesterol interact to regulate CETP gene expression. Treating SW872 cells with 
25-0H cholesterol and oleic acid together increased the expression of3200CETP.CAT 
with no change in the expression of 150CETP.CAT and 650CETP.CAT when 
PPARaiRXRa were cotransfected along with CETP.CAT gene chimeras (Figure 3.16). 
This finding is different from treatment with oleic acid alone that increased the 
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expression of650CETP.CAT with no effect on 3200CETP.CAT when CETP.CAT gene 
chimeras were cotransfected with PP ARa./RXRa. These results suggest that a) cholesterol 
interferes with the ability of oleic acid to stimulate CETP expression of 650CETP. CAT, 
and b) there might be other factors involved located within -650 bp to -3200 bp of the 
CETP promoter which are activated by both cholesterol and oleic acid. 
Treatment ofSW 872 cells with both 25-0H cholesterol and oleic acid increased 
the expression of650CETP.CAT when coexpressed along with LX.Ra and RX.Ra to the 
same extent as observed with 25-0H cholesterol alone (Figure 3.17). This suggests that 
oleic acid has no effect on cholesterol mediated induction of650CETP.CAT via 
LXRufR.XRa. On the other hand, giving 25-0H cholesterol and oleic acid together 
increased the expression of3200CETP.CAT but 25-0H cholesterol alone had no effect 
(Figure 3.13 ). These observations again suggest that there might be other factors 
involved which interact with the -650 bp to -3200 bp 5' regulatory region ofCETP which 
are activated by both oleic acid and cholesterol. 
Different responses ofCETP.CAT gene chimeras to oleic acid and cholesterol 
when transfected with either PP ARa.IR.XRa or LXRa!R.XRa suggests that LX.Ra, RXRa 
and PP ARa. might cross talk to regulate CETP gene expression. Oleic acid and 
cholesterol had no effect on the expression of650CETP.CAT when cells were 
cotransfected with LXRa, PP ARa., and RXRa (Figure 3.18). There was also no effect 
seen in 650CETP.CAT expression when oleic acid and cholesterol were added to cells 
coexpressing PP ARa. and RX.Ra. However, when cells are cotransfected with 
LXRa!RXRa, cholesterol and oleic acid increased 650CETP.CAT expression. These 
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results suggest that the presence ofboth cholesterol and oleic acid prevents the activation 
of the respective transcription factors, i.e. LXRu.IR.XRa and PP ARu./R.XRx. The addition 
of oleic acid to a cholesterol supplemented diet in hamsters prevented a cholesterol 
mediated increase in CETP activity (Kurushima eta/., 1995a) further confirming that 
oleic acid and cholesterol interfere with each other in regulating CETP, perhaps by 
disrupting the binding and/or activation oftranscription factors. 
Previous studies have shown that LXR and PP AR interact in vitro (Miyata eta/. , 
1996). LX:Ru binds directly to PPA:Ru and RXRu but LX:Ru/PPA:Ru does not form a DNA 
binding complex to PPRE or LX:Ru response elements (LXRE). L~ inhibits binding of 
PP ARu.IR.XRa to PPRE and antagonizes peroxisome proliferator signaling mediated by 
PP ARu!RXRu. On the other hand, PP ARu inhibits binding of LX:Ru/RX:Ru to LXRE. Our 
results in these transfection experiments suggest that there is some kind of interaction 
between the three transcription factors to regulate the CETP gene expression and this 
effect depends on the availability of the ligands. 
4.3.5 Regulation of the human CETP chimeric gene constructs by stearic acid 
The addition of dietary cholesterol to the SF A diet had no significant effect on 
CETP gene expression in CETP-TG mice (Figure 3.5). However, the regulation ofCETP 
by stearic acid itself is not known. Thus, in vitro experiments were performed to 
investigate whether stearic acid regulates CETP gene expression directly and whether 
cholesterol interferes with this regulation. 
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Treatment oftransfected SW 872 cells with stearic acid decreased the expression 
of650CETP.CAT with no change in the expression of 150CETP.CAT and 
3200CETP.CAT, when coexpressed with PP~IRXRx (Figure 3.19). This suggests that 
stearic acid has an opposite effect compared to oleic acid on CETP gene regulation, and 
that the effect is again contained within the 650 bp region of the CETP 5' regulatory 
regiOn. 
Transfected SW 872 cells coexpressing PP AR:.. and RXRa treated with 25-0H 
cholesterol and stearic acid decrease the expression of650CETP.CAT (Figure 3.20). The 
decrease in 650CETP.CAT expression also occurred with stearic acid alone suggesting 
that cholesterol does not interfere with stearic acid mediated down regulation of the 
CETP gene expression. 
The addition of stearic acid abolished the cholesterol mediated increase in 
650CETP.CAT expression in transfected SW 872 cells coexpressing LXRa/RXRx 
(Figure 3.21). These results suggest that stearic acid interferes with cholesterol mediated 
induction ofCETP gene expression. The expression of3200CETP.CAT decreased when 
stearic acid and 25-0H cholesterol were added to the culture medium of transfected 
SW 872 cells coexpressing LXRx and RXRa (Figure 3.21). This decrease was not 
observed when the transfected cells were treated with 25-0H cholesterol alone. The 
effect of stearic acid on CETP gene expression is opposite to that of oleic acid. However, 
the response to fatty acids and cholesterol when added together to the culture medium of 
transfected cells points towards a possible interaction between fatty acids and cholesterol, 
and the transcription factors involved. 
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To investigate whether LXRa, PP ARa, and RXRa. interact to regulate CETP gene 
expression, SW 872 cells were transfected with CETP.CAT gene chimeras along with 
LXRa, PP ARa, and RXRa.. Stearic acid and 25-0H cholesterol treatment of the 
transfected cells decreased the expression of 150CETP.CAT and 650CETP.CAT (Figure 
3.22). The extent of inhibition was greater compared to the cells coexpressing 
PP ARaiRXRa and treated with stearic acid and cholesterol. It is clear from stearic acid 
and oleic acid treatment experiments that fatty acids and cholesterol, and the respective 
transcription factors interact to regulate CETP gene expression. 
4.4 Conclusions 
The addition of cholesterol to a high fat MUF A diet inhibited CETP activity and 
hepatic mRNA abundance. However, the addition of cholesterol to a high fat SF A diet 
enhanced CETP activity but had no significant effect on hepatic CETP mRNA 
abundance. Oleic acid and stearic acid showed opposite effects in cell culture studies 
using CETP .CAT chimeric gene constructs indicating that the type of fat has different 
effects on CETP regulation. Moreover, the addition of cholesterol to various fats showed 
different results, suggesting that there is an interaction between cholesterol and fatty 
acids to regulate CETP. Whether this interaction is at the level of transcription factors is 
not clear from our study. Further investigations need to be carried out to understand how 
various fatty acids interact with cholesterol in CETP regulation. The understanding of 
regulation of metabolic pathways by cholesterol together with various fatty acids is 
crucial as these dietary components are normally consumed simultaneously. 
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